<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1621358</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2025.1621358</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Dual role of lactate in human health and disease</article-title>
<alt-title alt-title-type="left-running-head">Kumar et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2025.1621358">10.3389/fphys.2025.1621358</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kumar</surname>
<given-names>Sudhir</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2723974/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahu</surname>
<given-names>Neha</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/490469/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jawaid</surname>
<given-names>Talha</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1163069/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jayasingh Chellammal</surname>
<given-names>Hanish Singh</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2063714/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Upadhyay</surname>
<given-names>Prabhat</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1054919/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Microbiology and Immunology</institution>, <institution>School of Medicine</institution>, <institution>Emory University</institution>, <addr-line>Atlanta</addr-line>, <addr-line>GA</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Botany</institution>, <institution>University of Lucknow</institution>, <addr-line>Lucknow</addr-line>, <addr-line>Uttar Pradesh</addr-line>, <country>India</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>College of Medicine</institution>, <institution>Imam Mohammad Ibn Saud Islamic University (IMSIU)</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Pharmacology and Life Sciences</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Universiti Teknologi MARA (UiTM)</institution>, <addr-line>Puncak Alam</addr-line>, <addr-line>Selangor</addr-line>, <country>Malaysia</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Vincent Centre for Reproductive Biology</institution>, <institution>Department of Obstetrics and Gynecology</institution>, <institution>Massachusetts General Hospital</institution>, <institution>Harvard Medical School Boston</institution>, <addr-line>Boston</addr-line>, <addr-line>MA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/65956/overview">Charles Mobbs</ext-link>, Icahn School of Medicine at Mount Sinai, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/795021/overview">Elen H. Miyabara</ext-link>, University of S&#xe3;o Paulo, Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/956156/overview">John Andr&#xe9;s Quiroga Ardiles</ext-link>, Universidad Austral de Chile, Chile</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Prabhat Upadhyay, <email>pupadhyay@mgh.harvard.edu</email>, <email>upadhyayprabhat.89@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1621358</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Kumar, Sahu, Jawaid, Jayasingh Chellammal and Upadhyay.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Kumar, Sahu, Jawaid, Jayasingh Chellammal and Upadhyay</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Lactate, traditionally seen as a byproduct of anaerobic metabolism, has gained attention for its dual role in human health. While it is associated with muscle fatigue, lactate also plays a crucial role in various physiological and pathological processes. This review explores lactate&#x2019;s dual nature as both beneficial and detrimental. Under normal physiological conditions, lactate is an essential energy substrate, involved in the Cori cycle, where it is converted back to glucose in the liver. However, excessive lactate accumulation is linked to health issues, including cancer, metabolic disorders, and neurological diseases. The Warburg effect in cancer, characterized by increased lactate production even in oxygen-rich environments, promotes tumor progression and therapy resistance. In diseases like malaria and ischemic stroke, high lactate levels contribute to tissue damage and metabolic disturbances. Recent research also highlights lactate&#x2019;s beneficial roles, including regulation of immune responses, enhanced exercise performance, and neuronal signaling. Furthermore, gut microbiota significantly impacts lactate metabolism, where beneficial bacteria use lactate to maintain gut health, while some pathogenic bacteria exacerbate disease through excess lactate production. Emerging therapeutic potential of lactate, including lactate dehydrogenase inhibitors, offers promising treatment avenues. This review provides a comprehensive overview of lactate&#x2019;s complex role in health and disease, emphasizing the need for targeted strategies to harness its benefits while mitigating its harmful effects.</p>
</abstract>
<kwd-group>
<kwd>lactate</kwd>
<kwd>lactate dehydrogenase</kwd>
<kwd>cancer</kwd>
<kwd>metabolic disorders</kwd>
<kwd>gut microbiota</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Metabolic Physiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Lactate, first discovered in 1780, was long considered a metabolic waste product generated under hypoxic conditions. However, the lactate shuttle hypothesis redefined its role, highlighting its function in oxidative metabolism, gluconeogenesis, and cellular signaling. Contrary to early misconceptions, lactate is actively produced and utilized under aerobic conditions, serving as a key modulator of systemic metabolism. It is transported via monocarboxylate transporters (MCTs) and signals through G protein-coupled receptor 81 (GPR81) (<xref ref-type="bibr" rid="B49">Lee, 2021</xref>).</p>
<p>In exercise physiology, lactate accumulation has traditionally been linked to muscle fatigue, though it is now recognized as an important energy source and metabolic regulator. In oncology, Otto Warburg&#x2019;s 1920s discovery of aerobic glycolysis, where tumors ferment glucose into lactate even in oxygen-rich conditions, revealed lactate&#x2019;s role in tumor metabolism. This Warburg effect is also observed in various non-cancerous conditions, including inflammatory diseases and metabolic disorders. Beyond cancer, lactate accumulation contributes to pathophysiological processes in pulmonary hypertension, pulmonary fibrosis, heart failure, atherosclerosis, and polycystic kidney disease (<xref ref-type="fig" rid="F1">Figure 1</xref>). It is involved in stress responses during trauma, infection, and myocardial infarction. Moreover, lactate plays a crucial role in epigenetic regulation through lactylation, a posttranslational modification of histones that influences gene expression, particularly in inflammation and tumor progression (<xref ref-type="bibr" rid="B61">Mandadzhiev, 2025</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Pathophysiological impacts of lactate accumulation and acidosisElevated lactate levels leading to acidosis are implicated in various systemic complications, including digestive complications, septic shock, sepsis, and thrombus formation. Neurological effects include neurotoxicity and traumatic brain injury, while pulmonary consequences involve pulmonary fibrosis and respiratory failure. Lactate-driven acidosis also contributes to tumor microenvironment remodeling, promoting carcinogenicity. Furthermore, it is associated with cardiovascular diseases (such as atherosclerosis, heart failure, and myocardial infarction), liver damage leading to hepatic failure, and renal impairments, including polycystic kidney disease and renal failure.</p>
</caption>
<graphic xlink:href="fphys-16-1621358-g001.tif">
<alt-text content-type="machine-generated">Diagram titled &#x22;Pathophysiology of Lactate (Acidosis)&#x22; with icons and labels illustrating health issues: digestive complications, septic shock, neurotoxicity, pulmonary fibrosis, tumor microenvironment, cardiovascular disease, liver damage, carcinogenicity, and polycystic kidney disease, each represented by an organ or related symbol.</alt-text>
</graphic>
</fig>
<p>This review examines lactate&#x2019;s diverse functions in health and disease, emphasizing its roles in metabolic reprogramming, immune modulation, and disease progression, underscoring the need for further research on its broader physiological and pathological implications.</p>
</sec>
<sec id="s2">
<title>2 Lactate production and metabolism</title>
<p>Lactate synthesis occurs in the cytoplasm via lactate dehydrogenase (LDH), which catalyzes the conversion of pyruvate to lactate while regenerating NAD<sup>&#x2b;</sup> from NADH. This reaction is crucial for sustaining glycolysis under anaerobic or hypoxic conditions, ensuring ATP production when oxidative phosphorylation is impaired. The direction of this reversible reaction depends on oxygen availability, intracellular NADH/NAD<sup>&#x2b;</sup> ratios, and metabolic demands (<xref ref-type="bibr" rid="B49">Lee, 2021</xref>).</p>
<p>Under normoxic conditions, pyruvate enters the mitochondria for oxidation via the tricarboxylic acid (TCA) cycle, producing ATP efficiently. However, during hypoxia, intense exercise, or pathological conditions like ischemia and cancer, oxidative metabolism is restricted, leading to NADH accumulation. To maintain glycolytic flux, LDH reduces pyruvate to lactate, restoring NAD<sup>&#x2b;</sup> for continued glycolysis (<xref ref-type="bibr" rid="B54">Liu et al., 2025</xref>).</p>
<p>Lactate synthesis is regulated by enzyme isoforms, substrate availability, and signaling pathways. LDH exists as isoenzymes composed of LDHA and LDHB subunits, with tissue-specific functions. LDHA, predominant in glycolytic tissues like skeletal muscle, favors lactate production, while LDHB, abundant in oxidative tissues like the heart, facilitates lactate oxidation. The NADH/NAD<sup>&#x2b;</sup> ratio is a key determinant of LDH activity, with high NADH levels promoting lactate formation (<xref ref-type="bibr" rid="B109">Wang et al., 2018</xref>).</p>
<p>Cellular signaling also modulates lactate metabolism. Hypoxia-inducible factor 1-alpha (HIF-1&#x3b1;) upregulates glycolytic enzymes and LDHA under low oxygen conditions, enhancing lactate production. Adrenergic stimulation during exercise accelerates glycolytic flux, increasing lactate accumulation, whereas insulin and other metabolic regulators influence lactate utilization. Lactate is not merely a result of metabolism but a key intermediary in energy production. It is transported via MCTs and serves as a metabolic substrate in various tissues, supporting gluconeogenesis in the liver and oxidative metabolism in the heart, highlighting its role in systemic metabolic flexibility (<xref ref-type="bibr" rid="B119">Zhang T. et al., 2024</xref>).</p>
<sec id="s2-1">
<title>2.1 Physiological processes</title>
<p>Once regarded merely as a metabolic waste product generated during anaerobic glycolysis, lactate has emerged as a pivotal metabolic and signaling molecule integral to diverse physiological and pathological processes. Traditionally associated with muscle fatigue during intense exercise, lactate&#x2019;s role extends far beyond a simple byproduct; it serves as an essential energy substrate, a regulator of cellular metabolism, and a mediator of intercellular communication (<xref ref-type="bibr" rid="B104">Vav&#x159;i&#x10d;ka et al., 2024</xref>).</p>
<p>In cancer biology, lactate&#x2019;s significance is profound. Tumors commonly exhibit a metabolic shift known as aerobic glycolysis or the &#x201c;Warburg effect,&#x201d; where glucose is preferentially converted to lactate despite sufficient oxygen availability (<xref ref-type="bibr" rid="B121">Zhong et al., 2022</xref>). This metabolic reprogramming leads to lactate accumulation within the tumor microenvironment, which promotes cancer cell proliferation, angiogenesis, and metastasis (<xref ref-type="bibr" rid="B20">de la Cruz-L&#xf3;pez et al., 2019</xref>). Elevated lactate also contributes to immune evasion by creating an acidic microenvironment that suppresses cytotoxic T cell and natural killer cell activity, facilitating tumor progression (<xref ref-type="bibr" rid="B33">Gu et al., 2025</xref>). Research has demonstrated that lactate acts through signaling pathways such as HIF-1&#x3b1; stabilization and GPR81 activation, further reinforcing cancer cell survival and immune modulation (<xref ref-type="bibr" rid="B15">Chen et al., 2025</xref>). Beyond oncology, lactate is implicated in several chronic inflammatory and metabolic diseases (<xref ref-type="bibr" rid="B49">Lee, 2021</xref>). For instance, in pulmonary hypertension and pulmonary fibrosis, elevated lactate levels correlate with vascular remodeling and fibrotic processes (<xref ref-type="bibr" rid="B75">Peng et al., 2025</xref>). Studies indicate that lactate stimulates fibroblast activation and extracellular matrix deposition, contributing to disease progression (<xref ref-type="bibr" rid="B10">Caslin et al., 2021</xref>). In heart failure and atherosclerosis, abnormal lactate metabolism is associated with impaired mitochondrial function and chronic inflammation. Elevated circulating lactate in these conditions reflects underlying tissue hypoxia and metabolic stress, exacerbating cardiac dysfunction and vascular pathology (<xref ref-type="bibr" rid="B123">Zymli&#x144;ski et al., 2018</xref>; <xref ref-type="bibr" rid="B122">Zhu et al., 2024</xref>). Polycystic kidney disease (PKD) also features altered lactate metabolism. Experimental models show that lactate accumulation in cystic epithelial cells supports their proliferation and survival, contributing to cyst growth (<xref ref-type="bibr" rid="B30">Ghazi et al., 2019</xref>; <xref ref-type="bibr" rid="B73">Pagliarini and Podrini, 2021</xref>). Similarly, metabolic disorders such as type 2 diabetes exhibit dysregulated lactate production, linking it to insulin resistance and chronic low-grade inflammation (<xref ref-type="bibr" rid="B69">Nareika et al., 2005</xref>; <xref ref-type="bibr" rid="B112">Wu et al., 2016</xref>). Lactate involvement extends to acute stress responses, including trauma, infection, myocardial infarction, and ischemia-reperfusion injury (<xref ref-type="bibr" rid="B107">Wang et al., 2025</xref>). Here, lactate serves as both a metabolic fuel for damaged tissues and a signaling molecule triggering adaptive responses. Elevated lactate levels in sepsis, for example, are a prognostic marker reflecting tissue hypoperfusion and metabolic derangement (<xref ref-type="bibr" rid="B55">Liu et al., 2024</xref>).</p>
<p>A groundbreaking discovery expanding lactate role in disease is its function in epigenetic regulation through histone lactylation. This recently identified posttranslational modification involves the addition of lactate-derived groups to histone lysine residues, altering chromatin structure and gene expression. Histone lactylation has been shown to modulate inflammatory gene expression in macrophages, promoting resolution of inflammation, while also contributing to oncogenic gene programs in cancer cells. This epigenetic mechanism underscores lactate&#x2019;s capacity to link metabolic states with long-term changes in cellular phenotype and disease outcomes (<xref ref-type="bibr" rid="B116">Zhang et al., 2019</xref>).</p>
<p>Collectively, lactate acts as a critical mediator of metabolic adaptation, immune regulation, and pathophysiological remodeling across a spectrum of diseases. Its dual roles as an energy substrate and signaling molecule highlight the intricate connections between metabolism and cellular function. Ongoing research aims to eKMCTlucidate therapeutic strategies targeting lactate metabolism and signaling, offering promising avenues for treating cancer, inflammatory disorders, cardiovascular diseases, and metabolic syndromes. Understanding lactate&#x2019;s diverse physiological and pathological functions is essential for developing novel interventions to modulate disease progression and improve patient outcomes (<xref ref-type="bibr" rid="B51">Li et al., 2022</xref>).</p>
</sec>
<sec id="s2-2">
<title>2.2 Key sites of lactate production</title>
<p>During vigorous exercise, skeletal muscles rely on anaerobic glycolysis, resulting in substantial lactate accumulation. Once thought to be simply a product of glycolysis, lactate is now recognized as a vital signaling molecule and energy source. It can be shuttled to the liver for gluconeogenesis or oxidized in oxidative muscle fibers and the heart. Lactate also modulates gene expression related to mitochondrial biogenesis and angiogenesis, supporting muscle adaptation during endurance training (<xref ref-type="bibr" rid="B61">Mandadzhiev, 2025</xref>).</p>
<p>Erythrocytes, which lack mitochondria, depend entirely on anaerobic glycolysis for ATP production and continuously produce lactate. Recent studies highlight the role of MCTs in lactate transport, essential for maintaining acid-base balance. Erythrocyte-derived lactate significantly influences systemic metabolism, particularly in the heart and brain, and emerging evidence suggests its levels may serve as biomarkers for metabolic disorders such as diabetes and sepsis (<xref ref-type="bibr" rid="B119">Zhang T. et al., 2024</xref>).</p>
<p>In the brain, lactate plays a vital role through the astrocyte-neuron lactate shuttle. Astrocytes convert glucose into lactate, which neurons utilize during heightened activity. Lactate supports synaptic plasticity, learning, and memory by enhancing brain-derived neurotrophic factor (BDNF) signaling. Impaired lactate metabolism is linked to neurodegenerative diseases like Alzheimer&#x2019;s and Parkinson&#x2019;s, highlighting its therapeutic potential in cognitive disorders (<xref ref-type="bibr" rid="B3">Beard et al., 2022</xref>).</p>
<p>Cancer cells exhibit the Warburg effect, favoring glycolysis even in oxygen-rich environments, leading to lactate accumulation. This promotes immune evasion, angiogenesis, metastasis, and epigenetic changes that drive tumor aggressiveness. Lactate transporters such as MCT1 and MCT4 are emerging targets, with their inhibition shown to reduce tumor progression in breast cancer models. Modulating lactate metabolism offers a promising strategy for cancer therapy (<xref ref-type="bibr" rid="B121">Zhong et al., 2022</xref>).</p>
</sec>
<sec id="s2-3">
<title>2.3 Lactate metabolism</title>
<p>Lactate is transported to the liver, heart, and oxidative muscle fibers, where it converts to pyruvate and enters the TCA cycle for ATP production (<xref ref-type="bibr" rid="B109">Wang et al., 2018</xref>). The lactate shuttle hypothesis, first introduced by Brooks (1985), describes lactate&#x2019;s movement between glycolytic and oxidative tissues as a fuel source. The heart preferentially utilizes lactate as an energy substrate, with lactate oxidation playing a substantial role in myocardial energy production during both resting and stressed states (<xref ref-type="bibr" rid="B6">Brooks, 2021</xref>; <xref ref-type="bibr" rid="B118">Zhang H. et al., 2024</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). Through the Cori cycle, lactate is transported to the liver for gluconeogenesis (<xref ref-type="fig" rid="F2">Figure 2</xref>), forming glucose that is released into the bloodstream (<xref ref-type="bibr" rid="B63">Melkonian et al., 2023</xref>). Lactate homeostasis is maintained through MCTs 1&#x2013;4, enabling rapid cellular exchange (<xref ref-type="fig" rid="F2">Figure 2</xref>). Elevated lactate levels (lactic acidosis) signal metabolic dysregulation. Lactate&#x2019;s clearance mechanisms include oxidation via the TCA cycle, renal excretion through sodium/lactate transporters (Slc5a12 and Slc5a8), and microbiome incorporation (<xref ref-type="bibr" rid="B49">Lee, 2021</xref>). In a study, it has been demonstrated that hepatic gluconeogenesis is essential for glucose homeostasis during exercise and fasting (<xref ref-type="bibr" rid="B65">Meyer et al., 2002</xref>). The kidneys also contribute significantly, accounting for approximately 40% of systemic glucose production during prolonged fasting. Recent research challenges the traditional view of lactate as a glycolytic byproduct, showing that it directly fuels mitochondrial oxidative phosphorylation. Lactate enters mitochondria via the mitochondrial lactate oxidation complex (mLOC) and converts into pyruvate for ATP generation (<xref ref-type="bibr" rid="B7">Brooks et al., 2022</xref>). <xref ref-type="bibr" rid="B36">Hashimoto et al. (2008)</xref> provided compelling evidence that lactate oxidation occurs within mitochondria, highlighting its role in both normal and pathological states such as cancer and neurodegeneration (<xref ref-type="bibr" rid="B36">Hashimoto et al., 2008</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Beneficial role of lactate in human health and underlying mechanisms.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Beneficial role</th>
<th align="left">Mechanism</th>
<th align="left">Relevant system/Organ</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Energy substrate</td>
<td align="left">Provides an efficient fuel source for muscles, heart, and brain</td>
<td align="left">Muscle, Heart, Brain</td>
<td align="left">
<xref ref-type="bibr" rid="B36">Hashimoto et al. (2008)</xref>
</td>
</tr>
<tr>
<td align="left">Muscle adaptation</td>
<td align="left">Enhances mitochondrial biogenesis and oxidative capacity</td>
<td align="left">Skeletal muscle</td>
<td align="left">
<xref ref-type="bibr" rid="B68">Nalbandian et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left">Neuroprotection</td>
<td align="left">Supports neuronal metabolism, prevents excitotoxicity, and enhances synaptic plasticity</td>
<td align="left">Brain</td>
<td align="left">
<xref ref-type="bibr" rid="B96">Suzuki et al. (2011)</xref>
</td>
</tr>
<tr>
<td align="left">Immune modulation</td>
<td align="left">Regulates macrophage polarization, suppresses inflammation, and supports Treg function</td>
<td align="left">Immune system</td>
<td align="left">
<xref ref-type="bibr" rid="B119">Zhang et al. (2024b)</xref>
</td>
</tr>
<tr>
<td align="left">Angiogenesis and wound healing</td>
<td align="left">Stimulates vascular endothelial growth factor (VEGF) production</td>
<td align="left">Endothelial cells, Skin</td>
<td align="left">
<xref ref-type="bibr" rid="B41">Hunt et al. (2007)</xref>
</td>
</tr>
<tr>
<td align="left">Gluconeogenesis</td>
<td align="left">Serves as a precursor for glucose production via the Cori cycle</td>
<td align="left">Liver</td>
<td align="left">
<xref ref-type="bibr" rid="B86">Rogatzki et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">Lipid metabolism regulation</td>
<td align="left">Modulates free fatty acid (FFA) oxidation and storage</td>
<td align="left">Adipose tissue</td>
<td align="left">
<xref ref-type="bibr" rid="B4">Bergman et al. (1999)</xref>
</td>
</tr>
<tr>
<td align="left">Exercise recovery</td>
<td align="left">Reduces muscle fatigue, maintains pH balance, and promotes lactate shuttling</td>
<td align="left">Muscle</td>
<td align="left">
<xref ref-type="bibr" rid="B31">Gladden (2004)</xref>
</td>
</tr>
<tr>
<td align="left">Cancer metabolism</td>
<td align="left">Supports tumor cell survival and immune evasion in the tumor microenvironment</td>
<td align="left">Tumor microenvironment</td>
<td align="left">
<xref ref-type="bibr" rid="B27">Fischer et al. (2007)</xref>
</td>
</tr>
<tr>
<td align="left">Cardioprotection</td>
<td align="left">Preferred substrate over glucose in ischemic conditions, reducing oxidative stress</td>
<td align="left">Heart</td>
<td align="left">
<xref ref-type="bibr" rid="B13">Chatham (2002)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Lactate metabolism, signaling pathways, and its systemic impact on homeostasis and immunity. Food intake and viral infections drive glycolysis, leading to pyruvate and lactate production. Lactate is transported across membranes by MCT1&#x26; MCT4 and shuttled between tissues such as skeletal muscle and liver via the Cori cycle. Intracellularly, lactate modulates signaling through ARRB2-Gi protein-coupled pathways, reducing cAMP/PKA activity and influencing immunosuppression, inflammation, lipolysis, wound healing, angiogenesis, and neuroprotection. Lactate also serves as a metabolic fuel, supporting redox balance, gluconeogenesis, and exercise performance. In the cytoplasm, lactate-derived short-chain fatty acids (SCFAs) from gut microbiota contribute to systemic homeostasis. Lactate can inhibit mitochondrial antiviral signaling (MAVS) and RIG-I-mediated antiviral responses, reducing IFN-&#x3b1;/&#x3b2; production. Additionally, lactate enters the nucleus and promotes histone lactylation, driving epigenetic regulation of homeostatic gene expression.</p>
</caption>
<graphic xlink:href="fphys-16-1621358-g002.tif">
<alt-text content-type="machine-generated">Diagram illustrating lactate metabolism and its effects. Lactate shuttles between the liver, skeletal muscle, and circulation, influencing glucose and pyruvate. It impacts immune response, metabolism, exercise performance, and gene regulation. Components include MCT transporters, the Cori cycle, gut microbiota interactions, and cellular functions related to lactylation. Viruses and food influence glycolysis and pyruvate levels, with downstream effects on ATP synthesis, mitochondria, and histone modification.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-4">
<title>2.4 Physiological roles of lactate</title>
<p>Lactate serves as an efficient energy source, particularly in oxidative tissues like the heart and brain. The heart preferentially oxidizes lactate over glucose, emphasizing its role in cardiac metabolism (<xref ref-type="bibr" rid="B49">Lee, 2021</xref>). <xref ref-type="bibr" rid="B90">Schurr et al. (1999)</xref> demonstrated that lactate is a primary energy source for neurons, reinforcing its significance beyond glycolysis (<xref ref-type="bibr" rid="B90">Schurr et al., 1999</xref>). Lactate regulates gene expression, angiogenesis, and immune responses (<xref ref-type="fig" rid="F2">Figure 2</xref>). Lactate promotes the stabilization of HIF-1&#x3b1; by inhibiting prolyl hydroxylase activity. This stabilization enhances HIF-1-mediated transcription of glycolytic enzymes and VEGF, supporting metabolic adaptation and angiogenesis under hypoxic or pseudohypoxic conditions (<xref ref-type="bibr" rid="B51">Li et al., 2022</xref>). A study demonstrated that lactate accumulation under hypoxic conditions enhances VEGF expression, facilitating angiogenesis and tissue survival. Lactate accumulation during high-intensity exercise leads to metabolic acidosis but is rapidly cleared and utilized as an energy source. It aids recovery by replenishing glycogen stores and supporting mitochondrial respiration (<xref ref-type="bibr" rid="B61">Mandadzhiev, 2025</xref>). <xref ref-type="bibr" rid="B32">Gladden and Hogan (2006)</xref> showed that lactate metabolism during and after exercise is crucial for sustaining muscle function and preventing fatigue (<xref ref-type="bibr" rid="B32">Gladden and Hogan, 2006</xref>). Lactate is essential for brain metabolism. The astrocyte-neuron lactate shuttle theory suggests that astrocytes produce lactate, which neurons use as an energy source. Lactate enhances synaptic plasticity and memory formation (<xref ref-type="bibr" rid="B40">Hu et al., 2021</xref>). <xref ref-type="bibr" rid="B74">Pellerin et al. (1994)</xref> identified lactate as a key neuronal energy substrate, while another study showed that lactate enhances long-term memory formation in animal models (<xref ref-type="bibr" rid="B74">Pellerin et al., 1994</xref>). Lactate influences immune cell metabolism and function, regulating macrophage polarization. It promotes anti-inflammatory M2 macrophages while inhibiting pro-inflammatory M1 macrophages. This is particularly relevant in cancer metabolism and immune evasion (<xref ref-type="bibr" rid="B119">Zhang T. et al., 2024</xref>). In research study showed that lactate accumulation in tumors promotes M2 macrophage polarization, contributing to immune suppression and tumor progression (<xref ref-type="bibr" rid="B121">Zhong et al., 2022</xref>). Cancer cells convert glucose to lactate even in oxygen-rich conditions, a phenomenon known as the Warburg effect. Lactate accumulation in the tumor microenvironment promotes angiogenesis, immune evasion, and metastasis. Warburg first described this metabolic shift, and more recent studies highlighted how lactate metabolism supports tumor growth and resistance to therapy. Lactate is a vital metabolic intermediate with diverse roles beyond glycolysis. Its involvement in energy production, signaling, neuroprotection, and immune modulation underscores its physiological significance. The traditional perception of lactate as a waste product has evolved into its recognition as a key player in metabolic homeostasis (<xref ref-type="bibr" rid="B70">Nath and Balling, 2024</xref>).</p>
<p>In summary (<xref ref-type="table" rid="T1">Table 1</xref>), Lactate, an energy substrate, efficiently fuels muscles, the heart, and the brain, especially under high-demand conditions (<xref ref-type="bibr" rid="B36">Hashimoto et al., 2008</xref>). In skeletal muscle, lactate promotes adaptation by enhancing mitochondrial biogenesis and oxidative capacity, thereby improving endurance and performance (<xref ref-type="bibr" rid="B68">Nalbandian et al., 2017</xref>). In the brain, it supports neuronal metabolism, prevents excitotoxicity, and enhances synaptic plasticity, contributing to neuroprotection (<xref ref-type="bibr" rid="B96">Suzuki et al., 2011</xref>). Lactate also plays a crucial role in immune modulation by regulating macrophage polarization, suppressing inflammation, and supporting regulatory T cell function (<xref ref-type="bibr" rid="B119">Zhang T. et al., 2024</xref>). Furthermore, it stimulates angiogenesis and wound healing by promoting vascular endothelial growth factor (VEGF) production in endothelial cells and skin (<xref ref-type="bibr" rid="B41">Hunt et al., 2007</xref>). In the liver, lactate serves as a precursor for gluconeogenesis via the Cori cycle, helping to maintain blood glucose levels (<xref ref-type="bibr" rid="B86">Rogatzki et al., 2015</xref>). Its influence extends to lipid metabolism, where it modulates free fatty acid oxidation and storage in adipose tissue (<xref ref-type="bibr" rid="B4">Bergman et al., 1999</xref>). During exercise recovery, lactate helps reduce muscle fatigue, maintain pH balance, and facilitate lactate shuttling between tissues (<xref ref-type="bibr" rid="B31">Gladden, 2004</xref>). Interestingly, in the tumor microenvironment, lactate supports cancer cell survival and immune evasion (<xref ref-type="bibr" rid="B27">Fischer et al., 2007</xref>). Lastly, in the heart, lactate serves as a preferred substrate over glucose during ischemic conditions, offering cardioprotection by reducing oxidative stress (<xref ref-type="bibr" rid="B13">Chatham, 2002</xref>). Collectively, these findings highlight lactate&#x2019;s multifaceted and beneficial roles across various organs and systems, challenging its outdated reputation as merely a metabolic waste product. In the following section, we provide a detailed explanation of key aspects highlighted in (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>3 The boon: beneficial role of lactate</title>
<sec id="s3-1">
<title>3.1 Lactate as an energy source</title>
<p>Glycolysis, a key metabolic pathway, processes glucose to generate ATP and essential precursors for cellular functions. While glycolysis contributes only &#x223c;6% of cellular ATP via substrate-level phosphorylation, its regulation by enzymes such as hexokinase (HEX), phosphofructokinase (PFK), and pyruvate kinase (PK) is crucial. Pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC) further link glycolysis to mitochondrial metabolism. Traditionally considered a waste product of anaerobic metabolism, lactate is now recognized as a critical energy source. It is converted to pyruvate by lactate dehydrogenase (LDH) and utilized by muscles, the heart, and the brain for oxidative phosphorylation, particularly during exercise or metabolic stress (<xref ref-type="bibr" rid="B14">Chaudhry and Varacallo, 2023</xref>).</p>
<p>Lactate, first identified in sour milk through microbial fermentation, becomes the predominant metabolite in mammals when oxygen and ATP demands surpass supply. Contrary to its reputation as a metabolic waste product, lactate is now understood as a key circulating carbohydrate fuel. By balancing the NADH/NAD&#x2b; ratio, lactate serves as both an energy substrate and a redox buffer, facilitating metabolic flexibility. This shift in perspective redefines lactate&#x2019;s role in energy metabolism (<xref ref-type="bibr" rid="B51">Li et al., 2022</xref>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Lactate as a preferred fuel</title>
<p>During physical exertion, skeletal muscles and the heart preferentially utilize lactate over glucose and fatty acids. In the brain, the Astrocyte-Neuron Lactate Shuttle (ANLS) facilitates lactate transfer from astrocytes to neurons, promoting energy metabolism and neuroprotection (<xref ref-type="bibr" rid="B11">Cauli et al., 2023</xref>). Recent findings challenge the notion that lactate is merely converted to pyruvate in the cytosol; instead, it is processed in mitochondria via the Mitochondrial Lactate Oxidation Complex (mLOC), particularly in high-energy-demand tissues (<xref ref-type="bibr" rid="B16">Chen et al., 2016</xref>).</p>
<p>In resting humans, the lactate-to-pyruvate (L/P) ratio is &#x223c;10, increasing to &#x223c;500 during moderate exercise, underscoring lactate&#x2019;s role in metabolic adaptation. Major lactate utilization pathways include intramuscular oxidation, cardiac uptake, and hepatic gluconeogenesis (<xref ref-type="bibr" rid="B54">Liu et al., 2025</xref>).</p>
</sec>
<sec id="s3-3">
<title>3.3 Lactate and lipid metabolism</title>
<p>An inverse relationship exists between lactate and plasma free fatty acids (FFAs) during exercise. Lactate inhibits lipolysis in adipose tissue via Hydroxycarboxylic Acid Receptor 1 (HCAR1), modulating cAMP and CREB signaling pathways. Additionally, lactate impacts mitochondrial fatty acid oxidation by increasing acetyl-CoA and malonyl-CoA levels, inhibiting &#x3b2;-oxidation (<xref ref-type="bibr" rid="B53">Liu et al., 2009</xref>).</p>
<p>Lactate-induced secretion of Transforming Growth Factor Beta 2 (TGF-&#x3b2;2) from adipose tissue enhances glucose tolerance, highlighting its role in interorgan metabolic communication. These findings emphasize lactate&#x2019;s dual role in acute metabolic regulation and long-term adaptation (<xref ref-type="bibr" rid="B54">Liu et al., 2025</xref>).</p>
</sec>
<sec id="s3-4">
<title>3.4 Lactate in brain energy metabolism and neuroprotection</title>
<p>Neurons rely on astrocytes for metabolic support. While glucose remains the primary fuel, lactate serves as an essential alternative, particularly during hypoglycemia or ischemic stress. Lactate supplementation enhances recovery from traumatic brain injury (TBI) and supports memory formation by modulating epigenetic mechanisms and brain-derived neurotrophic factor (BDNF) expression. Lactate metabolism is altered in neurodegenerative diseases like Alzheimer&#x2019;s and Parkinson&#x2019;s, with reduced lactate transport linked to cognitive decline. Enhancing lactate availability may offer therapeutic benefits in restoring metabolic balance and neuroprotection (<xref ref-type="bibr" rid="B3">Beard et al., 2022</xref>).</p>
</sec>
<sec id="s3-5">
<title>3.5 Lactate as a cellular signal and epigenetic modulator</title>
<p>Beyond metabolism, lactate functions as a signaling molecule influencing angiogenesis, tissue repair, and gene expression. It activates G-protein coupled receptors such as HCAR1, regulating neuroprotection and lipid metabolism. A novel post-translational modification, histone lactylation, links lactate to gene regulation (<xref ref-type="fig" rid="F2">Figure 2</xref>). Increased lactate production under hypoxia or bacterial infections drives histone lactylation, influencing macrophage polarization, tumor progression, and inflammation resolution. These positions lactate as a crucial metabolic and epigenetic regulator with broad physiological and pathological implications (<xref ref-type="bibr" rid="B116">Zhang et al., 2019</xref>).</p>
</sec>
<sec id="s3-6">
<title>3.6 Lactate in hypoxia and cancer metabolism</title>
<p>Lactate stabilizes HIF-1&#x3b1;, promoting angiogenesis and metabolic adaptation under low-oxygen conditions. Lactate signaling plays a central role in tumor metabolism and immune evasion; thus, its targeting represents an emerging avenue for cancer therapeutics (<xref ref-type="bibr" rid="B33">Gu et al., 2025</xref>).</p>
</sec>
<sec id="s3-7">
<title>3.7 Lactate in exercise adaptation and immune modulation</title>
<p>Lactate modulates mitochondrial biogenesis and endurance adaptations through AMP-activated protein kinase (AMPK) and PGC-1&#x3b1; signaling. It also influences immune responses, shaping macrophage polarization and cytokine production, with implications for inflammation, metabolism, and disease progression (<xref ref-type="bibr" rid="B97">Takeda et al., 2022</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>4 Gut microbiota: fuel or metabolize excess lactate</title>
<sec id="s4-1">
<title>4.1 Lactate production by gut bacteria</title>
<p>Lactic Acid Bacteria (LAB) have adapted to survive in different environments, including the human gut, by relying primarily on fermentation for energy production. Unlike many other bacteria, LAB cannot perform respiration because they lack functional cytochromes, which are essential for oxidative metabolism. Instead, they obtain energy by breaking down sugars into lactic acid, which acidifies their surroundings and helps them outcompete harmful bacteria (<xref ref-type="bibr" rid="B108">Wang et al., 2020</xref>).</p>
<p>LAB have evolved unique metabolic pathways that enable their survival in diverse environments, particularly within the human gut. Among these pathways, amino acid deamination serves as a crucial mechanism for energy production, allowing LAB to thrive in nutrient-poor conditions by converting amino acids into usable energy. Additionally, acid decarboxylation plays a fundamental role in maintaining pH balance, which is essential for LAB survival in acidic environments such as the gastrointestinal tract (<xref ref-type="bibr" rid="B26">Feng and Wang, 2020</xref>).</p>
<p>Beyond their metabolic adaptability, LAB engage in intricate interactions with host cells, significantly influencing gut health and immune function. Through cross-talk with the host, LAB can modulate intestinal gene expression, thereby impacting digestive processes and immune responses. Furthermore, LAB contributes to gut homeostasis by producing bioactive compounds, such as gamma-aminobutyric acid (GABA), which not only relaxes gut smooth muscles but also has broader implications for mood regulation. Another essential feature of LAB is their antimicrobial effect, primarily mediated by lactic acid production. It acidifies the gut environment and inhibits the growth of pathogenic bacteria, thereby fostering a balanced microbiome (<xref ref-type="bibr" rid="B115">Yu et al., 2024</xref>).</p>
<p>Lactate plays a dual role in gut health. On the one hand, it serves as an important metabolic intermediate, supporting the growth of lactate-consuming bacteria, which convert it into beneficial SCFAs (<xref ref-type="table" rid="T4">Table 4</xref>). On the other hand, excessive lactate accumulation can lead to acidosis, which disrupts microbial stability. This phenomenon is well-documented in ruminants, where diets rich in fermentable carbohydrates can promote the overgrowth of lactate-producing bacteria, causing a dangerous drop in pH and leading to metabolic disorders such as lactic acidosis. In the human gut, lactate metabolism is tightly regulated through cross-feeding interactions between different bacterial species (<xref ref-type="bibr" rid="B115">Yu et al., 2024</xref>).</p>
</sec>
<sec id="s4-2">
<title>4.2 Lactate utilization by gut microbes</title>
<sec id="s4-2-1">
<title>4.2.1 Butyrate production</title>
<p>Certain members of the phylum Firmicutes, particularly species belonging to the genera <italic>Anaerobutyricum</italic> and <italic>Anaerostipes</italic>, are capable of converting lactate into butyrate, a SCFA with well-established health benefits. This conversion typically occurs via a cross-feeding mechanism that requires acetate as a co-substrate. Butyrate is a critical energy source for colonocytes, where it enhances intestinal barrier function, regulates inflammatory pathways, and modulates the gut immune response. Additionally, butyrate has been associated with anti-inflammatory effects through its role in the inhibition of histone deacetylases (HDACs), contributing to immune homeostasis within the gut mucosa (<xref ref-type="fig" rid="F3">Figure 3</xref>) (<xref ref-type="bibr" rid="B59">Louis et al., 2022</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Impact of lactate on gut microbiota: balancing beneficial and harmful effects. Lactate influences gut microbiota composition, supporting beneficial bacteria such as <italic>Faecalibacterium prausnitzii</italic>, <italic>Roseburia</italic> spp., <italic>Bifidobacterium</italic>, <italic>Lactobacillus</italic>, <italic>Eubacterium hallii</italic>, and <italic>Anaerostipes</italic>, which enhance gut barrier integrity, improve immune function, and produce SCFAs like butyrate, propionate, and acetate. In contrast, elevated lactate levels can promote the growth of harmful bacteria, including <italic>Veillonella</italic>, <italic>Propionibacterium</italic>, <italic>E. coli</italic>, <italic>Salmonella</italic>, <italic>Enterococcus faecalis</italic>, and <italic>Clostridium</italic> spp., leading to reduced gut pH, increased inflammation via pro-inflammatory cytokines (TNF-&#x3b1;, ILs, IFN-&#x3b3;), impaired gut barrier function, and a higher risk of gastrointestinal infections.</p>
</caption>
<graphic xlink:href="fphys-16-1621358-g003.tif">
<alt-text content-type="machine-generated">Diagram showing gut bacteria, divided into beneficial and harmful sections by a mucin layer. Beneficial bacteria include Bifidobacterium and Lactobacillus, promoting gut barrier function and immune health. Harmful bacteria like E. coli and Salmonella lower gut pH and cause inflammation. Short-chain fatty acids are converted from lactate, improving immune function.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s4-2-2">
<title>4.2.2 Propionate formation</title>
<p>Lactate can also be metabolized into propionate via multiple biochemical pathways, with distinct microbial taxa utilizing different metabolic route.</p>
</sec>
<sec id="s4-2-3">
<title>4.2.3 Acrylate pathway</title>
<p>This pathway involves the direct conversion of lactate into propionate and is employed by bacterial species such as <italic>Coprococcus catus</italic> (<xref ref-type="bibr" rid="B83">Reichardt et al., 2014</xref>) and <italic>Megasphaera elsdenii</italic> (<xref ref-type="bibr" rid="B38">Hino and Kuroda, 1993</xref>).</p>
</sec>
<sec id="s4-2-4">
<title>4.2.4 Succinate pathway</title>
<p>In this pathway, lactate is first converted to succinate, which is subsequently metabolized into propionate. This process is utilized by species within the genus <italic>Veillonella</italic> (<xref ref-type="bibr" rid="B83">Reichardt et al., 2014</xref>).</p>
</sec>
<sec id="s4-2-5">
<title>4.2.5 1,2-Propanediol pathway</title>
<p>An alternative route involves the conversion of lactate into 1,2-propanediol, which can then be further metabolized into propionate by species such as <italic>Limosilactobacillus reuteri</italic> and <italic>Anaerobutyricum hallii</italic> (<xref ref-type="bibr" rid="B71">Niu et al., 2019</xref>).</p>
<p>Propionate serves multiple physiological functions in the host, including modulating gluconeogenesis in the liver, influencing appetite regulation, and exerting anti-inflammatory properties through interactions with gut epithelial and immune cells (<xref ref-type="bibr" rid="B59">Louis et al., 2022</xref>).</p>
</sec>
<sec id="s4-2-6">
<title>4.2.6 Acetate production and sulfate reduction</title>
<p>Certain <italic>Proteobacteria</italic>, including species within the genus <italic>Desulfovibrio</italic>, are capable of metabolizing lactate into acetate through dissimilatory sulfate reduction. This process is coupled with the production of hydrogen sulfide (H<sub>2</sub>S), a metabolite that, at excessive levels, has been implicated in gut epithelial damage and inflammatory conditions such as inflammatory bowel disease (IBD). While low concentrations of H<sub>2</sub>S may have physiological roles in cell signaling, its accumulation can lead to mucosal toxicity and alterations in gut microbiota composition (<xref ref-type="bibr" rid="B85">Rey et al., 2013</xref>).</p>
<p>The microbial conversion of lactate into butyrate, propionate, and acetate plays a pivotal role in gut ecosystem stability and host physiology. Cross-feeding interactions between lactate-producing and lactate-utilizing bacteria regulate metabolite flux, influencing gut barrier integrity, immune function, and metabolic homeostasis (<xref ref-type="bibr" rid="B24">Dordevi&#x107; et al., 2020</xref>).</p>
</sec>
<sec id="s4-2-7">
<title>4.2.7 Cross-feeding among microbes</title>
<p>Bacterial cross-feeding plays a crucial role in shaping SCFA production and optimizing substrate utilization in the gut. These interactions enhance microbial diversity, prevent metabolic imbalances, and contribute to gut health by maintaining a stable environment. <italic>Bifidobacterium</italic> produces acetate when fermenting dietary fibers such as oligofructose, which is then utilized by butyrate-producing bacteria like <italic>Faecalibacterium prausnitzii</italic> and <italic>Roseburia</italic> sp. to produce butyrate. Lactate-producing bacteria like <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> produce lactate during carbohydrate fermentation, which can be converted into butyrate by <italic>Eubacterium hallii</italic> and <italic>Anaerostipes</italic> to prevent acid build-up and contribute to gut health. Propionate-producing bacteria (<italic>Veillonella</italic>, <italic>Propionibacterium</italic>) convert lactate into propionate, playing a role in glucose metabolism and satiety (<xref ref-type="fig" rid="F3">Figure 3</xref>) (<xref ref-type="bibr" rid="B18">Culp and Goodman, 2023</xref>).</p>
</sec>
</sec>
<sec id="s4-3">
<title>4.3 Implications for intestinal homeostasis</title>
<p>Lactate plays a significant role in gut health, immunity, and disease prevention. If lactate-consuming bacteria are insufficient, lactate can accumulate, leading to a drop in pH and potential gut dysbiosis. Excess lactate has been linked to inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and metabolic disorders (<xref ref-type="bibr" rid="B108">Wang et al., 2020</xref>). Colonocytes (intestinal cells) utilize lactate to produce butyrate through cross-feeding by bacteria such as <italic>Eubacterium</italic> and <italic>Anaerostipes</italic>, which strengthen the gut lining and support overall intestinal health. Lactate lowers the pH, inhibiting harmful bacteria (<italic>Escherichia coli</italic>, <italic>Salmonella</italic>) while promoting beneficial microbes (<italic>Bifidobacteria</italic>, <italic>Akkermansia</italic>) (<xref ref-type="bibr" rid="B120">Zhao et al., 2024</xref>). Additionally, lactate helps regulate immune responses by modulating immune cells and reducing inflammatory cytokines (TNF-&#x3b1;, IL-6), preventing excessive inflammation (<xref ref-type="bibr" rid="B58">Llibre et al., 2025</xref>).</p>
<p>Recent studies highlight the pivotal role of lactate and its receptor, GPR81, in regulating intestinal homeostasis and immune responses, particularly in inflammatory bowel diseases (IBD) (<xref ref-type="bibr" rid="B81">Ranganathan et al., 2018</xref>). Understanding these metabolic pathways and their microbial contributors provides valuable insight into potential probiotic interventions aimed at promoting gut health and preventing dysbiosis-associated diseases (<xref ref-type="bibr" rid="B51">Li et al., 2022</xref>).</p>
</sec>
</sec>
<sec id="s5">
<title>5 Lactate dehydrogenase (LDH) inhibitors: plant-based and synthetic</title>
<p>Lactate dehydrogenase (LDH) plays a crucial role in anaerobic glycolysis by catalyzing the reversible conversion of pyruvate to lactate, coupled with the regeneration of NAD<sup>&#x2b;</sup>. In cancer, this pathway is hijacked even under aerobic conditions, a phenomenon known as the Warburg effect, whereby cancer cells preferentially convert glucose to lactate despite sufficient oxygen. This metabolic reprogramming supports rapid cell proliferation by sustaining glycolytic flux, maintaining redox balance, and promoting survival in the tumor microenvironment. LDH, particularly the LDH-A isoform, is thus considered a key metabolic enzyme and a promising therapeutic target in cancers (<xref ref-type="bibr" rid="B103">Valvona et al., 2016</xref>; <xref ref-type="bibr" rid="B46">Kim et al., 2019</xref>) and infectious diseases like malaria (<xref ref-type="bibr" rid="B79">Possemiers et al., 2021</xref>). LDH belongs to the 2-hydroxyacid oxidoreductase family and is widely found in animals, microorganisms, yeasts, and plants. The <xref ref-type="table" rid="T2">Table 2</xref> summarizes various plant-based LDH inhibitors, highlighting their mechanisms of action and implications for human health (<xref ref-type="table" rid="T2">Table 2</xref>). Natural compounds such as pentagalloyl glucose from Rhus chinensis, polyphenols (including quercetin, EGCG, curcumin, and resveratrol), and berberine target LDH through different mechanisms, such as non-competitive inhibition, binding to the enzyme&#x2019;s active or coenzyme sites, and suppression of LDH expression. These inhibitors show potential in cancer therapy by disrupting tumor metabolism, overcoming drug resistance, and modulating lactate production. Additionally, some compounds like those from Polygala tenuifolia demonstrate neuroprotective effects in ischemic stroke, while others, such as rutin and amentoflavone from Selaginella doederleinii, offer potential treatments for metabolic disorders. Overall, plant-based LDH inhibitors present promising therapeutic avenues for cancer, metabolic diseases, and neuroprotection (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Summarizes the plant-based and synthetic LDH inhibitors.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Category</th>
<th align="left">LDH inhibitor</th>
<th align="left">Role/Mechanism</th>
<th align="left">Implications for human health</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Plant-Based Inhibitors</td>
<td align="left">
<italic>Rhus chinensis</italic>
</td>
<td align="left">Pentagalloyl glucose (PGG) inhibits LDH non-competitively, reducing lactate in cancer cells</td>
<td align="left">Potential cancer therapy by disrupting metabolic processes in tumors</td>
<td align="left">
<xref ref-type="bibr" rid="B64">Mendonca et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">
<italic>Polygala tenuifolia</italic>
</td>
<td align="left">Identified five LDH inhibitors, a potential treatment for ischemic stroke</td>
<td align="left">Neuroprotective effects in ischemic stroke</td>
<td align="left">
<xref ref-type="bibr" rid="B92">Shen et al. (2025)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Rutin</td>
<td align="left">Binds to the coenzyme site of LDH, inhibiting its activity in a dose-dependent manner</td>
<td align="left">Modulates lactate production, useful in various metabolic disorders</td>
<td align="left">
<xref ref-type="bibr" rid="B22">Ding et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">
<italic>Selaginella doederleinii</italic>
</td>
<td align="left">Amentoflavone and robustaflavone inhibit LDH</td>
<td align="left">Potential treatment for metabolic disorders and cancer</td>
<td align="left">
<xref ref-type="bibr" rid="B117">Zhang et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Polyphenols (Quercetin, EGCG, Curcumin, Resveratrol)</td>
<td align="left">Binds to the LDH active site, reduces its activity, and suppresses LDH expression</td>
<td align="left">Anti-cancer and anti-inflammatory effects, metabolic modulation</td>
<td align="left">
<xref ref-type="bibr" rid="B35">Han et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Catechin</td>
<td align="left">Inhibits lactate production and LDHA activity, overcomes 5FU resistance in cancer</td>
<td align="left">Potential adjuvant therapy for drug resistance in cancer</td>
<td align="left">
<xref ref-type="bibr" rid="B35">Han et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Berberine</td>
<td align="left">Targets LDH-A, suppressing pancreatic cancer progression via AMPK/mTOR pathway</td>
<td align="left">Potential cancer therapy, metabolic disorder treatment</td>
<td align="left">
<xref ref-type="bibr" rid="B19">Davoodvandi et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Betulinic Acid</td>
<td align="left">Binds strongly to LDH, reducing its activity, and exerting antitumor effects</td>
<td align="left">Anti-cancer properties, modulates lactate production in tumors</td>
<td align="left">
<xref ref-type="bibr" rid="B19">Davoodvandi et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">Synthetic Inhibitors</td>
<td align="left">Pyrazole-based inhibitors</td>
<td align="left">Block LDH enzymatic activity, developed through high-throughput screening</td>
<td align="left">Potential cancer and metabolic disorder therapy</td>
<td align="left">
<xref ref-type="bibr" rid="B80">Rai et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Galloflavin</td>
<td align="left">Inhibits LDH-A and LDH-B, induces apoptosis in tumor cells</td>
<td align="left">Selective anticancer agent, blocks aerobic glycolysis in tumors</td>
<td align="left">
<xref ref-type="bibr" rid="B114">Yao et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Oxamate</td>
<td align="left">Inhibits LDH-A in NSCLC cells, reduces ATP levels and induces apoptosis</td>
<td align="left">Targeting LDH-A for cancer therapy, particularly in lung cancer</td>
<td align="left">
<xref ref-type="bibr" rid="B50">Li et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">GSK2837808A</td>
<td align="left">Specific LDH-A inhibitor, reduces lactate secretion in TMJOA synovial fibroblasts</td>
<td align="left">Potential treatment for joint disorders and metabolic dysfunctions</td>
<td align="left">
<xref ref-type="bibr" rid="B2">Alobaidi et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">FX-11 and AR-C155858</td>
<td align="left">Combination therapy targeting LDHA and MCT1, reducing tumor cell proliferation</td>
<td align="left">Effective in breast and colorectal cancer treatment</td>
<td align="left">
<xref ref-type="bibr" rid="B2">Alobaidi et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">N-hydroxyindole-based inhibitor (NHI-Glc-2)</td>
<td align="left">Inhibits glycolysis and cell proliferation in cancer</td>
<td align="left">Potential anticancer agent with antiglycolytic effects</td>
<td align="left">
<xref ref-type="bibr" rid="B37">Hassouni et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Itraconazole, Atorvastatin, Posaconazole</td>
<td align="left">Potential inhibitors of Plasmodium LDH, with posaconazole most effective</td>
<td align="left">Treatment for malaria, particularly against Plasmodium LDH</td>
<td align="left">
<xref ref-type="bibr" rid="B17">Comandatore et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Stiripentol</td>
<td align="left">Antiepileptic drug, inhibits LDH, reducing seizures and epileptiform activity</td>
<td align="left">Potential treatment for epilepsy, reducing lactate-related neuronal activity</td>
<td align="left">
<xref ref-type="bibr" rid="B111">Wheless and Weatherspoon (2025)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Beyond its metabolic role, LDH is an important diagnostic marker, as its sudden increase in serum levels often indicates acute disease conditions. High LDH levels are commonly observed in malignancies, megaloblastic anemia, myocardial infarction, liver disorders, hematological diseases, and skeletal muscle conditions. Due to its strong clinical significance, LDH measurement is widely used for disease diagnosis and monitoring (<xref ref-type="bibr" rid="B34">Gupta, 2022</xref>).</p>
<sec id="s5-1">
<title>5.1 LDH in malaria and cancer</title>
<p>In <italic>Plasmodium falciparum</italic> (the parasite responsible for malaria), the enzyme pfLDH is essential for energy production, as the parasite relies on anaerobic glycolysis due to the absence of a citric acid cycle. Inhibitors of pfLDH could potentially lead to the death of the malaria parasite (<xref ref-type="bibr" rid="B76">Penna-Coutinho et al., 2011</xref>). Similarly, in cancer, human LDH isoform-5 (hLDH-5 or LDH-A) is upregulated in tumor cells, supporting the Warburg effect, where tumors rely more on anaerobic glycolysis than oxidative phosphorylation for energy. Targeting hLDH-5 could disrupt tumor growth and invasiveness (<xref ref-type="bibr" rid="B1">Alam et al., 2014</xref>).</p>
</sec>
</sec>
<sec id="s6">
<title>6 The curse: potential detrimental effects of lactate</title>
<sec id="s6-1">
<title>6.1 Lactic acidosis and metabolic dysregulation</title>
<p>While lactate serves as a critical metabolic intermediate, excessive accumulation can lead to lactic acidosis, a pathological condition characterized by a decrease in blood pH. This occurs in cases of severe hypoxia, sepsis, or mitochondrial dysfunction, where lactate clearance is impaired. Studies have shown that elevated lactate levels in critically ill patients are associated with poor outcomes due to systemic metabolic disturbances (<xref ref-type="table" rid="T3">Table 3</xref>) (<xref ref-type="bibr" rid="B51">Li et al., 2022</xref>). Recently, research highlighted the role of excessive lactate in disrupting cellular homeostasis, leading to impaired enzyme function and metabolic stress (<xref ref-type="bibr" rid="B8">Cai et al., 2024</xref>).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Summary of the impact of excess lactate on human health and the mechanisms involved in disease progression.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Effect</th>
<th align="left">Mechanism</th>
<th align="left">Relevant organs</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Cancer progression</td>
<td align="left">Lactate supports tumor growth by driving enhanced glycolysis and suppressing immune responses</td>
<td align="left">Tumors (Various organs)</td>
<td align="left">
<xref ref-type="bibr" rid="B20">de la Cruz-L&#xf3;pez et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Increased inflammation</td>
<td align="left">Lactate accumulation can activate inflammatory pathways and cytokine release</td>
<td align="left">Immune system, tissues</td>
<td align="left">
<xref ref-type="bibr" rid="B58">Llibre et al. (2025)</xref>
</td>
</tr>
<tr>
<td align="left">Metabolic disorders</td>
<td align="left">High lactate levels contribute to metabolic dysfunction, affecting glucose and lipid metabolism</td>
<td align="left">Liver, muscles, adipose tissue</td>
<td align="left">
<xref ref-type="bibr" rid="B42">Ishitobi et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Muscle fatigue</td>
<td align="left">Accumulation of lactate in muscles leads to acidosis and impairs muscle contraction</td>
<td align="left">Skeletal muscles</td>
<td align="left">
<xref ref-type="bibr" rid="B15">Chen et al. (2025)</xref>
</td>
</tr>
<tr>
<td align="left">Brain dysfunction</td>
<td align="left">Lactate buildup in the brain may contribute to neurological diseases like epilepsy and Alzheimer&#x2019;s</td>
<td align="left">Brain (CNS)</td>
<td align="left">
<xref ref-type="bibr" rid="B9">Cai et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">Cardiac stress</td>
<td align="left">Elevated lactate in the heart can cause reduced oxygen availability, increasing the risk of ischemia</td>
<td align="left">Heart</td>
<td align="left">
<xref ref-type="bibr" rid="B25">Fang et al. (2024)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Excessive lactate accumulation, as detailed in <xref ref-type="table" rid="T3">Table 3</xref>, has significant implications for human health by contributing to the progression of various diseases. In cancer, elevated lactate levels promote tumor growth through enhanced glycolysis and suppression of immune responses, affecting multiple organs (<xref ref-type="bibr" rid="B20">de la Cruz-L&#xf3;pez et al., 2019</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>). Lactate buildup can also activate inflammatory pathways and cytokine release, leading to increased inflammation in the immune system and other tissues (<xref ref-type="bibr" rid="B58">Llibre et al., 2025</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>). Metabolic disorders arise when high lactate concentrations disrupt glucose and lipid metabolism, particularly impacting the liver, muscles, and adipose tissue (<xref ref-type="bibr" rid="B42">Ishitobi et al., 2019</xref>). In skeletal muscles, lactate accumulation results in acidosis and impairs muscle contraction, contributing to muscle fatigue (<xref ref-type="bibr" rid="B15">Chen et al., 2025</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>). The brain is also vulnerable, as lactate buildup may play a role in neurological diseases such as epilepsy and Alzheimer&#x2019;s (<xref ref-type="bibr" rid="B9">Cai et al., 2022</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>). Lastly, in the heart, elevated lactate can reduce oxygen availability and increase the risk of ischemia (<xref ref-type="bibr" rid="B25">Fang et al., 2024</xref>) (<xref ref-type="table" rid="T3">Table 3</xref>). This summary underscores the multifaceted and detrimental effects of excess lactate on various organ systems.</p>
</sec>
<sec id="s6-2">
<title>6.2 Tumor microenvironment and cancer progression</title>
<p>The Warburg effect, a hallmark of cancer metabolism, leads to high lactate production, which significantly alters the tumor microenvironment. Accumulated lactate promotes immune evasion, angiogenesis, and metastasis by modulating tumor-associated macrophages and regulatory T cells. Studies have shown that lactate enhances HIF-1&#x3b1; stabilization, upregulating VEGF expression and supporting tumor growth. In study showed that targeting lactate transporters, such as MCT1 and MCT4, can disrupt tumor metabolism and enhance the efficacy of cancer therapies (<xref ref-type="bibr" rid="B121">Zhong et al., 2022</xref>).</p>
</sec>
<sec id="s6-3">
<title>6.3 Cardiovascular disease and impaired cardiac function</title>
<p>Elevated lactate levels are frequently observed in cardiovascular diseases, especially in conditions like heart failure and ischemic injury, where tissue hypoxia impairs oxidative metabolism. The heart preferentially oxidizes lactate as an energy source under normal conditions; however, in pathological states, excessive lactate accumulation can contribute to acidosis and impaired myocardial function (<xref ref-type="bibr" rid="B72">Ouyang et al., 2023</xref>). A study illustrated that heart failure patients exhibit altered lactate metabolism, leading to reduced cardiac efficiency (<xref ref-type="bibr" rid="B84">Revelly et al., 2005</xref>). Moreover, lactate-driven inflammation in vascular endothelial cells has been implicated in atherosclerosis progression, highlighting the need for therapeutic strategies targeting lactate balance in cardiovascular health (<xref ref-type="bibr" rid="B23">Dong et al., 2021</xref>).</p>
</sec>
<sec id="s6-4">
<title>6.4 Neurological disorders and cognitive dysfunction</title>
<p>Dysregulated lactate metabolism has been implicated in neurodegenerative diseases, including Alzheimer&#x2019;s, Parkinson&#x2019;s, and multiple sclerosis. While lactate plays a neuroprotective role under physiological conditions, impaired lactate transport and utilization can contribute to neuronal energy deficits and oxidative stress (<xref ref-type="bibr" rid="B113">Yang et al., 2024</xref>). A research study demonstrated that disruptions in the astrocyte-neuron lactate shuttle lead to cognitive impairment (<xref ref-type="bibr" rid="B96">Suzuki et al., 2011</xref>). Furthermore, excessive lactate accumulation in the brain has been associated with neuroinflammation and excitotoxicity, exacerbating disease progression in conditions such as epilepsy and traumatic brain injury (<xref ref-type="bibr" rid="B87">Roh et al., 2023</xref>).</p>
</sec>
<sec id="s6-5">
<title>6.5 Muscular dystrophy and exercise intolerance</title>
<p>In individuals with muscular dystrophy and metabolic myopathies, lactate metabolism is often impaired, leading to exercise intolerance and muscle fatigue. Mutations affecting glycolytic enzymes or lactate transporters result in an inability to efficiently clear lactate, leading to muscle damage and weakness (<xref ref-type="bibr" rid="B44">Jeppesen et al., 2013</xref>). A study highlighted the role of lactate accumulation in muscle dysfunction, emphasizing its contribution to oxidative stress and mitochondrial impairment. Therapeutic approaches aimed at optimizing lactate metabolism are being explored to improve muscle function in dystrophic conditions (<xref ref-type="bibr" rid="B98">Tarnopolsky, 2018</xref>; <xref ref-type="bibr" rid="B110">Wen et al., 2025</xref>).</p>
</sec>
<sec id="s6-6">
<title>6.6 Lactate-producing bacteria harmful to human health</title>
<p>While many lactate-producing bacteria play beneficial roles in maintaining gut homeostasis, certain species can contribute to dysbiosis and inflammation when their growth is dysregulated (<xref ref-type="bibr" rid="B59">Louis et al., 2022</xref>). For instance, an overgrowth of <italic>Lactobacillus</italic> or <italic>Enterococcus</italic> species can lead to excessive lactate accumulation, which may exacerbate gastrointestinal conditions such as IBS, IBD, and even metabolic diseases like obesity. In these cases, the excess lactate can lower gut pH, leading to an imbalance in the microbiota and promoting the growth of pathogenic bacteria (<xref ref-type="fig" rid="F3">Figure 3</xref>; <xref ref-type="table" rid="T4">Table 4</xref>) (<xref ref-type="bibr" rid="B78">Portincasa et al., 2024</xref>).</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Summarized table of microbiota showing their beneficial and harmful impacts on human health in the presence of lactate.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Bacteria</th>
<th align="left">Category</th>
<th align="left">Mechanism of lactate production</th>
<th align="left">Impact on human health</th>
<th align="left">Potential health effects</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<italic>Lactobacillus</italic> spp. <italic>(Lactobacillus acidophilus; Lactobacillus casei)</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Ferments carbohydrates to produce lactate</td>
<td align="left">Helps maintain gut acidity, beneficial for digestion, and supports gut health by preventing pathogenic overgrowth</td>
<td align="left">Prevents pathogen colonization, supports immune function, and promotes gut barrier integrity</td>
<td align="left">
<xref ref-type="bibr" rid="B21">Dempsey and Corr (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Bifidobacterium</italic> spp.</td>
<td align="left">Beneficial</td>
<td align="left">Produces lactate from dietary fibers and oligosaccharides</td>
<td align="left">Modulates gut microbiota, improves gut health, and has anti-inflammatory effects</td>
<td align="left">Supports healthy digestion, reduces inflammation, and promotes the production of beneficial short-chain fatty acids</td>
<td align="left">
<xref ref-type="bibr" rid="B105">Victoria Obayomi et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Faecalibacterium prausnitzii</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Converts carbohydrates into lactate and butyrate</td>
<td align="left">Supports gut health and maintains a balanced microbiome</td>
<td align="left">Enhances anti-inflammatory responses and strengthens gut barrier function</td>
<td align="left">
<xref ref-type="bibr" rid="B62">Mart&#xed;n et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Lactobacillus plantarum</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Produces lactic acid by fermenting sugars in anaerobic conditions</td>
<td align="left">Promotes gut barrier integrity and reduces inflammation</td>
<td align="left">May help in managing irritable bowel syndrome (IBS) and other inflammatory conditions</td>
<td align="left">
<xref ref-type="bibr" rid="B56">Liu et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Lactobacillus rhamnosus</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Ferments glucose to lactic acid, regenerating NAD&#x2b; for glycolysis</td>
<td align="left">Strengthens gut microbiota and supports immune function</td>
<td align="left">Reduces risk of respiratory infections and improves skin health</td>
<td align="left">
<xref ref-type="bibr" rid="B82">Rastogi and Singh (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Lactobacillus reuteri</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Convert sugars to lactic acid via the lactate dehydrogenase enzyme</td>
<td align="left">Produces antimicrobial substances that inhibit pathogens</td>
<td align="left">May reduce colic in infants and improve oral health</td>
<td align="left">
<xref ref-type="bibr" rid="B93">Singh et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Streptococcus thermophilus</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Converts lactose to lactic acid during fermentation</td>
<td align="left">Aids in lactose digestion and supports gut health</td>
<td align="left">Reduces symptoms of lactose intolerance and improves gut microbiota</td>
<td align="left">
<xref ref-type="bibr" rid="B89">Saleem et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Enterococcus faecium</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Produces lactic acid as a byproduct of carbohydrate metabolism</td>
<td align="left">Competes with harmful bacteria in the gut</td>
<td align="left">May reduce the risk of gastrointestinal infections</td>
<td align="left">
<xref ref-type="bibr" rid="B106">Vieco-Saiz et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Pediococcus acidilactici</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Ferments sugars to lactic acid, lowering pH and inhibiting spoilage organisms</td>
<td align="left">Used in food preservation and supports gut health</td>
<td align="left">Enhances food safety and promotes gut microbiota balance</td>
<td align="left">
<xref ref-type="bibr" rid="B100">Todorov et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Leuconostoc mesenteroides</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Produces lactic acid and other metabolites during carbohydrate fermentation</td>
<td align="left">Contributes to food fermentation and supports gut health</td>
<td align="left">Improves digestion and enhances the flavor of fermented foods</td>
<td align="left">
<xref ref-type="bibr" rid="B47">Kim et al. (2025)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Weissella confusa</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Ferments sugars to lactic acid, producing antimicrobial compounds</td>
<td align="left">Inhibits harmful bacteria and supports gut health</td>
<td align="left">May reduce the risk of infections and improve gut microbiota</td>
<td align="left">
<xref ref-type="bibr" rid="B77">Petrariu et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Oenococcus oeni</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Converts malic acid to lactic acid during malolactic fermentation</td>
<td align="left">Used in winemaking and supports gut health</td>
<td align="left">Enhances the flavor of wine and promotes gut microbiota balance</td>
<td align="left">
<xref ref-type="bibr" rid="B43">James et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Carnobacterium maltaromaticum</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Produces lactic acid and bacteriocins during fermentation</td>
<td align="left">Inhibits spoilage organisms in food and supports gut health</td>
<td align="left">Enhances food safety and promotes gut microbiota balance</td>
<td align="left">
<xref ref-type="bibr" rid="B5">Bisht et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Propionibacterium freudenreichii</italic>
</td>
<td align="left">Beneficial</td>
<td align="left">Produces lactic acid and propionic acid during carbohydrate fermentation</td>
<td align="left">Supports gut health and produces vitamin B12</td>
<td align="left">Enhances nutrient absorption and reduces gut inflammation</td>
<td align="left">
<xref ref-type="bibr" rid="B101">Tripathi et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Streptococcus mutans</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Produces lactate from sugars, especially sucrose</td>
<td align="left">Key contributor to dental cavities and oral infections</td>
<td align="left">Causes tooth decay and promotes plaque formation</td>
<td align="left">
<xref ref-type="bibr" rid="B60">Luo et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Clostridium</italic> spp.</td>
<td align="left">Harmful</td>
<td align="left">Ferments carbohydrates to produce lactate, often in excess</td>
<td align="left">Overproduction of lactate in gut can lower pH, cause metabolic disturbances, and exacerbate gut inflammation</td>
<td align="left">Contributes to conditions like colorectal cancer, IBS, and IBD.</td>
<td align="left">
<xref ref-type="bibr" rid="B39">Hou et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Enterococcus faecalis</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Produces lactate from sugars under anaerobic conditions</td>
<td align="left">Associated with gut dysbiosis, promotes inflammation and infection, and is pathogenic in immunocompromised individuals.</td>
<td align="left">Can lead to sepsis, urinary tract infections, and gut-related issues like IBS and IBD.</td>
<td align="left">
<xref ref-type="bibr" rid="B12">Chancharoenthana et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Staphylococcus aureus</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Anaerobic fermentation of glucose</td>
<td align="left">Produces lactate, which can contribute to tissue damage and inflammation</td>
<td align="left">Causes skin infections, pneumonia, and toxic shock syndrome</td>
<td align="left">
<xref ref-type="bibr" rid="B99">Taylor and Unakal (2023)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Escherichia coli (E. coli)</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Glycolysis followed by fermentation under oxygen-limited conditions</td>
<td align="left">Lactate production can exacerbate inflammation in the gut</td>
<td align="left">Causes food poisoning, urinary tract infections, and septicemia</td>
<td align="left">
<xref ref-type="bibr" rid="B66">Milani et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Streptococcus pyogenes</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Lactic acid fermentation via the Embden-Meyerhof pathway</td>
<td align="left">Lactate can fuel bacterial growth and worsen tissue damage</td>
<td align="left">Causes strep throat, scarlet fever, and necrotizing fasciitis</td>
<td align="left">
<xref ref-type="bibr" rid="B95">Stevens and Bryant (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Clostridium perfringens</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Fermentation of pyruvate in anaerobic conditions</td>
<td align="left">Lactate production contributes to the acidic environment, aiding bacterial survival</td>
<td align="left">Causes gas gangrene and food poisoning</td>
<td align="left">
<xref ref-type="bibr" rid="B45">Juneja et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Lactobacillus acidophilus</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Homolactic fermentation, where glucose is converted entirely into lactate</td>
<td align="left">Overproduction of lactate can lead to acidosis in certain conditions</td>
<td align="left">Normally beneficial but can cause infections in immunocompromised individuals</td>
<td align="left">
<xref ref-type="bibr" rid="B29">Gao et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Propionibacterium acnes</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Fermentation of carbohydrates under anaerobic or oxygen-restricted conditions</td>
<td align="left">Lactate production can contribute to inflammation in sebaceous glands</td>
<td align="left">Associated with acne and other skin conditions</td>
<td align="left">
<xref ref-type="bibr" rid="B28">Gannesen et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Helicobacter pylori</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Adaptive metabolic pathways for survival in acidic stomach conditions</td>
<td align="left">Lactate production can alter the stomach&#x2019;s microenvironment, aiding bacterial colonization</td>
<td align="left">Causes stomach ulcers and is linked to gastric cancer</td>
<td align="left">
<xref ref-type="bibr" rid="B94">Somiah et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Klebsiella pneumoniae</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Facultative anaerobic fermentation of sugars</td>
<td align="left">Lactate production can worsen lung inflammation and tissue damage</td>
<td align="left">Causes pneumonia, urinary tract infections, and septicemia</td>
<td align="left">
<xref ref-type="bibr" rid="B52">Liang et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Pseudomonas aeruginosa</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Lactate synthesis during anaerobic respiration</td>
<td align="left">Lactate production supports biofilm formation, making infections harder to treat</td>
<td align="left">Causes infections in wounds, lungs, and urinary tract</td>
<td align="left">
<xref ref-type="bibr" rid="B67">Moser et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Enterococcus faecalis</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Fermentation via the glycolytic pathway</td>
<td align="left">Lactate production can contribute to biofilm formation and antibiotic resistance</td>
<td align="left">Causes urinary tract infections, endocarditis, and bacteremia</td>
<td align="left">
<xref ref-type="bibr" rid="B88">Said et al. (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Bacteroides fragilis</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Anaerobic glycolysis</td>
<td align="left">Lactate production can promote bacterial survival in anaerobic environments</td>
<td align="left">Causes abdominal infections and abscesses</td>
<td align="left">
<xref ref-type="bibr" rid="B102">Tufail and Schmitz (2024)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Clostridium difficile</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Lactic acid fermentation in low-oxygen environments</td>
<td align="left">Lactate production can disrupt gut microbiota balance</td>
<td align="left">Causes severe diarrhea and colitis</td>
<td align="left">
<xref ref-type="bibr" rid="B91">Sehgal and Khanna (2021)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Mycobacterium tuberculosis</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Modulation of metabolic pathways under hypoxic conditions</td>
<td align="left">Lactate production can contribute to the acidic environment in infected tissues</td>
<td align="left">Causes tuberculosis</td>
<td align="left">
<xref ref-type="bibr" rid="B48">Kiran and Basaraba (2021)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Neisseria gonorrhoeae</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Oxygen-limited glycolysis followed by fermentation</td>
<td align="left">Lactate production can enhance bacterial survival in mucosal tissues</td>
<td align="left">Causes gonorrhea</td>
<td align="left">
<xref ref-type="bibr" rid="B57">Llibre et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">
<italic>Salmonella enterica</italic>
</td>
<td align="left">Harmful</td>
<td align="left">Facultative fermentation of carbohydrates</td>
<td align="left">Lactate production can exacerbate gut inflammation and bacterial invasion</td>
<td align="left">Causes foodborne illnesses and typhoid fever</td>
<td align="left">
<xref ref-type="bibr" rid="B57">Llibre et al. (2021)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The <xref ref-type="table" rid="T4">Table 4</xref> highlights the beneficial roles of various gut bacteria in human health through their mechanisms of lactate production. <italic>Lactobacillus</italic> spp. (including L. acidophilus and L. casei) ferment carbohydrates to produce lactate, which helps maintain gut acidity, supports digestion, and prevents pathogenic overgrowth by enhancing immune function and barrier integrity. Bifidobacterium spp. generate lactate from dietary fibers and oligosaccharides, modulating the gut microbiota, improving gut health, and exerting anti-inflammatory effects by promoting the production of beneficial short-chain fatty acids. Faecalibacterium prausnitzii converts carbohydrates into lactate and butyrate, supporting a balanced microbiome and enhancing anti-inflammatory responses, thereby strengthening gut barrier function. <italic>Lactobacillus</italic> plantarum produces lactic acid under anaerobic conditions, promoting gut barrier integrity and potentially aiding in the management of irritable bowel syndrome (IBS) and other inflammatory conditions. Together, these bacteria contribute significantly to gut health by modulating inflammation, supporting digestion, and maintaining a balanced microbiome (<xref ref-type="table" rid="T4">Table 4</xref>).</p>
</sec>
</sec>
<sec id="s7">
<title>7 Conclusion and future directions</title>
<p>Lactate, once primarily associated with muscle fatigue and anaerobic metabolism, is increasingly recognized for its complex and dual role in human health. Under normal physiological conditions, lactate serves as a critical energy substrate and plays a pivotal role in metabolic processes like the Cori cycle. However, its excessive accumulation, particularly in diseases like cancer, ischemic stroke, and metabolic disorders, can be detrimental, contributing to disease progression and poor prognosis.</p>
<p>Recent studies have highlighted lactate&#x2019;s potential as both a boon and a curse. While its role in tumor metabolism, immune regulation, and neuronal signaling shows promise, the harmful effects of chronic lactate accumulation cannot be overlooked. The emerging therapeutic strategies targeting lactate, such as lactate dehydrogenase inhibitors, offer new avenues for disease treatment.</p>
<p>Future research should focus on developing precise methods to regulate lactate metabolism, exploring the role of gut microbiota in lactate production, and understanding the complex interactions between lactate and immune responses. Additionally, investigating the potential of lactate in enhancing exercise performance and as a therapeutic agent in neurological and metabolic diseases warrants attention. Ultimately, advancing our understanding of lactate&#x2019;s multifaceted role will enable the development of targeted interventions to harness its benefits while mitigating its harmful effects.</p>
</sec>
</body>
<back>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>SK: Methodology, Resources, Writing &#x2013; original draft, Writing &#x2013; review and editing, Software. NS: Writing &#x2013; original draft, Writing &#x2013; review and editing. TJ: Writing &#x2013; review and editing. HJ: Writing &#x2013; review and editing. PU: Conceptualization, Methodology, Resources, Supervision, Writing &#x2013; original draft, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Neyaz</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>S. I.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug development</article-title>. <source>Malar. Res. Treat.</source> <volume>2014</volume>, <fpage>451065</fpage>. <pub-id pub-id-type="doi">10.1155/2014/451065</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alobaidi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hashimi</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Alqosaibi</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>AlQurashi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Alhazmi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Targeting the monocarboxylate transporter MCT2 and lactate dehydrogenase A LDHA in cancer cells with FX-11 and AR-C155858 inhibitors</article-title>. <source>Eur. Rev. Med. Pharmacol. Sci.</source> <volume>27</volume>, <fpage>6605</fpage>&#x2013;<lpage>6617</lpage>. <pub-id pub-id-type="doi">10.26355/EURREV_202307_33131</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beard</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lengacher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Magistretti</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Finsterwald</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Astrocytes as key regulators of brain energy metabolism: new therapeutic perspectives</article-title>. <source>Front. Physiol.</source> <volume>12</volume>, <fpage>825816</fpage>. <pub-id pub-id-type="doi">10.3389/FPHYS.2021.825816</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergman</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Wolfel</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Butterfield</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Lopaschuk</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Casazza</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Horning</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>). <article-title>Active muscle and whole body lactate kinetics after endurance training in men</article-title>. <source>J. Appl. Physiol.</source> <volume>87</volume>, <fpage>1684</fpage>&#x2013;<lpage>1696</lpage>. <pub-id pub-id-type="doi">10.1152/JAPPL.1999.87.5.1684</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bisht</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Navani</surname>
<given-names>N. K.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Understanding of probiotic origin antimicrobial peptides: a sustainable approach ensuring food safety</article-title>. <source>npj Sci. Food</source> <volume>8</volume> (<issue>18</issue>), <fpage>67</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1038/s41538-024-00304-8</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooks</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Role of the heart in lactate shuttling</article-title>. <source>Front. Nutr.</source> <volume>8</volume>, <fpage>663560</fpage>. <pub-id pub-id-type="doi">10.3389/FNUT.2021.663560</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooks</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Curl</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Leija</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Osmond</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Duong</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Arevalo</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Tracing the lactate shuttle to the mitochondrial reticulum</article-title>. <source>Exp. &#x26; Mol. Med.</source> <volume>54</volume> (<issue>54</issue>), <fpage>1332</fpage>&#x2013;<lpage>1347</lpage>. <pub-id pub-id-type="doi">10.1038/s12276-022-00802-3</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Empowering mitochondrial metabolism: exploring L-lactate supplementation as a promising therapeutic approach for metabolic syndrome</article-title>. <source>Metabolism</source> <volume>152</volume>, <fpage>155787</fpage>. <pub-id pub-id-type="doi">10.1016/J.METABOL.2024.155787</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Lactate is answerable for brain function and treating brain diseases: energy substrates and signal molecule</article-title>. <source>Front. Nutr.</source> <volume>9</volume>, <fpage>800901</fpage>. <pub-id pub-id-type="doi">10.3389/FNUT.2022.800901</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caslin</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Abebayehu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pinette</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>J. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Lactate is a metabolic mediator that shapes immune cell fate and function</article-title>. <source>Front. Physiol.</source> <volume>12</volume>, <fpage>688485</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2021.688485</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cauli</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dusart</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Lactate as a determinant of neuronal excitability, neuroenergetics and beyond</article-title>. <source>Neurobiol. Dis.</source> <volume>184</volume>, <fpage>106207</fpage>. <pub-id pub-id-type="doi">10.1016/J.NBD.2023.106207</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chancharoenthana</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kamolratanakul</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Leelahavanichkul</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The leaky gut and the gut microbiome in sepsis &#x2013; targets in research and treatment</article-title>. <source>Clin. Sci. (Lond)</source> <volume>137</volume>, <fpage>645</fpage>&#x2013;<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1042/CS20220777</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chatham</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Lactate - the forgotten fuel</article-title>. <source>J. Physiology</source> <volume>542</volume>, <fpage>333</fpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2002.020974</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhry</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Varacallo</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2023</year>). <source>Biochemistry, glycolysis</source>. <publisher-loc>Treasure Island, FL</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK482303/">https://www.ncbi.nlm.nih.gov/books/NBK482303/</ext-link>(Accessed April 25, 2025)</comment>.</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Lactate and lactylation in cancer</article-title>. <source>Signal Transduct. Target. Ther.</source> <volume>10</volume> (<issue>1</issue>), <fpage>38</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/s41392-024-02082-x</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Mahieu</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>S. L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Lactate metabolism is associated with Mammalian mitochondria</article-title>. <source>Nat. Chem. Biol.</source> <volume>12</volume>, <fpage>937</fpage>&#x2013;<lpage>943</lpage>. <pub-id pub-id-type="doi">10.1038/NCHEMBIO.2172</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comandatore</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Franczak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smolenski</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Giovannetti</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Lactate dehydrogenase and its clinical significance in pancreatic and thoracic cancers</article-title>. <source>Semin. Cancer Biol.</source> <volume>86</volume>, <fpage>93</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/J.SEMCANCER.2022.09.001</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Culp</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Cross-feeding in the gut microbiome: ecology and mechanisms</article-title>. <source>Cell Host Microbe</source> <volume>31</volume>, <fpage>485</fpage>&#x2013;<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1016/J.CHOM.2023.03.016</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davoodvandi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sadeghi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alavi</surname>
<given-names>S. M. A.</given-names>
</name>
<name>
<surname>Alavi</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Jafari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>The therapeutic effects of berberine for gastrointestinal cancers</article-title>. <source>Asia Pac J. Clin. Oncol.</source> <volume>20</volume>, <fpage>152</fpage>&#x2013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1111/AJCO.13941</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de la Cruz-L&#xf3;pez</surname>
<given-names>K. G.</given-names>
</name>
<name>
<surname>Castro-Mu&#xf1;oz</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Reyes-Hern&#xe1;ndez</surname>
<given-names>D. O.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Carranc&#xe1;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Manzo-Merino</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Lactate in the regulation of tumor microenvironment and therapeutic approaches</article-title>. <source>Front. Oncol.</source> <volume>9</volume>, <fpage>1143</fpage>. <pub-id pub-id-type="doi">10.3389/FONC.2019.01143</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dempsey</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Corr</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Lactobacillus spp. for gastrointestinal health: current and future perspectives</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <fpage>840245</fpage>. <pub-id pub-id-type="doi">10.3389/FIMMU.2022.840245</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Exploring the therapeutic potential of rutin through investigating its inhibitory mechanism on lactate dehydrogenase: multi-Spectral methods and computer simulation</article-title>. <source>Bioorg Chem.</source> <volume>149</volume>, <fpage>107503</fpage>. <pub-id pub-id-type="doi">10.1016/J.BIOORG.2024.107503</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Lactate and myocardiac energy metabolism</article-title>. <source>Front. Physiol.</source> <volume>12</volume>, <fpage>715081</fpage>. <pub-id pub-id-type="doi">10.3389/FPHYS.2021.715081</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dordevi&#x107;</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jan&#x10d;&#xed;kov&#xe1;</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>V&#xed;t&#x11b;zov&#xe1;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kushkevych</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Hydrogen sulfide toxicity in the gut environment: meta-Analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes</article-title>. <source>J. Adv. Res.</source> <volume>27</volume>, <fpage>55</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/J.JARE.2020.03.003</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Emerging roles of lactate in acute and chronic inflammation</article-title>. <source>Cell Commun. Signal.</source> <volume>22</volume> (<issue>22</issue>), <fpage>276</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1186/S12964-024-01624-8</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review</article-title>. <source>Gut Microbes</source> <volume>12</volume>, <fpage>1801944</fpage>. <pub-id pub-id-type="doi">10.1080/19490976.2020.1801944</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Voelkl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meidenbauer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ammer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Edinger</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Inhibitory effect of tumor cell-derived lactic acid on human T cells</article-title>. <source>Blood</source> <volume>109</volume>, <fpage>3812</fpage>&#x2013;<lpage>3819</lpage>. <pub-id pub-id-type="doi">10.1182/BLOOD-2006-07-035972</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gannesen</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Zdorovenko</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Botchkova</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Hardouin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Massier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kopitsyn</surname>
<given-names>D. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Composition of the biofilm matrix of Cutibacterium acnes acneic strain RT5</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>, <fpage>1284</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.01284</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The functional roles of Lactobacillus acidophilus in different physiological and pathological processes</article-title>. <source>J. Microbiol. Biotechnol.</source> <volume>32</volume>, <fpage>1226</fpage>&#x2013;<lpage>1233</lpage>. <pub-id pub-id-type="doi">10.4014/JMB.2205.05041</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghazi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Polesel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Targeting glycolysis in proliferative kidney diseases</article-title>. <source>Am. J. Physiol. Ren. Physiol.</source> <volume>317</volume>, <fpage>F1531-F1535</fpage>&#x2013;<lpage>F1535</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00460.2019</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gladden</surname>
<given-names>L. B.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Lactate metabolism: a new paradigm for the third millennium</article-title>. <source>J. Physiology</source> <volume>558</volume>, <fpage>5</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1113/JPHYSIOL.2003.058701</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gladden</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>M. C.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Lactic acid accumulation is an advantage/disadvantage during muscle activity</article-title>. <source>J. Appl. Physiol.</source> <volume>100</volume>, <fpage>2100</fpage>&#x2013;<lpage>2101</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00213.2006</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z. J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives</article-title>. <source>Front. Immunol.</source> <volume>16</volume>, <fpage>1563303</fpage>. <pub-id pub-id-type="doi">10.3389/FIMMU.2025.1563303</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>G. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The lactate and the lactate dehydrogenase in inflammatory diseases and major risk factors in COVID-19 patients</article-title>. <source>Inflamm. 2022</source> <volume>45</volume> (<issue>6</issue>), <fpage>2091</fpage>&#x2013;<lpage>2123</lpage>. <pub-id pub-id-type="doi">10.1007/S10753-022-01680-7</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>H. S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases</article-title>. <source>Front. Pharmacol.</source> <volume>14</volume>, <fpage>1275000</fpage>. <pub-id pub-id-type="doi">10.3389/FPHAR.2023.1275000</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Mitochondrial lactate oxidation complex and an adaptive role for lactate production</article-title>. <source>Med. Sci. Sports Exerc</source> <volume>40</volume>, <fpage>486</fpage>&#x2013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0B013E31815FCB04</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassouni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Franczak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Capula</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vonk</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Smolenski</surname>
<given-names>R. T.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction</article-title>. <source>Oncoscience</source> <volume>7</volume>, <fpage>76</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.18632/ONCOSCIENCE.519</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Presence of lactate dehydrogenase and lactate racemase in Megasphaera elsdenii grown on glucose or lactate</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>59</volume>, <fpage>255</fpage>&#x2013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.59.1.255-259.1993</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z. X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Microbiota in health and diseases</article-title>. <source>Signal Transduct. Target. Ther.</source> <volume>7</volume> (<issue>1</issue>), <fpage>135</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1038/s41392-022-00974-4</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Elevated lactate by high-intensity interval training regulates the hippocampal BDNF expression and the mitochondrial quality control system</article-title>. <source>Front. Physiol.</source> <volume>12</volume>, <fpage>629914</fpage>. <pub-id pub-id-type="doi">10.3389/FPHYS.2021.629914</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bergsten</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Levkanicova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>St. John</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Wild</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>A comprehensive phylogeny of beetles reveals the evolutionary origins of a superradiation</article-title>. <source>Science</source> <volume>1979</volume> (<issue>318</issue>), <fpage>1913</fpage>&#x2013;<lpage>1916</lpage>. <pub-id pub-id-type="doi">10.1126/SCIENCE.1146954</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishitobi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hosaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murashima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kitahara</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Serum lactate levels are associated with serum alanine aminotransferase and total bilirubin levels in patients with type 2 diabetes mellitus: a cross-sectional study</article-title>. <source>Diabetes Res. Clin. Pract.</source> <volume>149</volume>, <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/J.DIABRES.2019.01.028</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Microbiota for production of wine with enhanced functional components</article-title>. <source>Food Sci. Hum. Wellness</source> <volume>12</volume>, <fpage>1481</fpage>&#x2013;<lpage>1492</lpage>. <pub-id pub-id-type="doi">10.1016/J.FSHW.2023.02.008</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeppesen</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Orngreen</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Van Hall</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vissing</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Lactate metabolism during exercise in patients with mitochondrial myopathy</article-title>. <source>Neuromuscul. Disord.</source> <volume>23</volume>, <fpage>629</fpage>&#x2013;<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1016/J.NMD.2013.05.007</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juneja</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Taneja</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Thakur</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>
<italic>Clostridium perfringens</italic> infection</article-title>. <source>Encycl. Food Saf.</source> (<issue>1&#x2013;4</issue>), <fpage>V2</fpage>&#x2013;<lpage>V128</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-822521-9.00089-7</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>E. Y.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>S. B.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A novel lactate dehydrogenase inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) benzene, suppresses tumor growth through apoptotic cell death</article-title>. <source>Sci. Rep. 2019</source> <volume>9</volume> (<issue>1</issue>), <fpage>3969</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-40617-3</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. H.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Modulation of fermentation dynamics in kimchi using Leuconostoc mesenteroides starter</article-title>. <source>Food Biosci.</source> <volume>66</volume>, <fpage>106317</fpage>. <pub-id pub-id-type="doi">10.1016/J.FBIO.2025.106317</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiran</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Basaraba</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Lactate metabolism and signaling in tuberculosis and cancer: a comparative review</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>11</volume>, <fpage>624607</fpage>. <pub-id pub-id-type="doi">10.3389/FCIMB.2021.624607</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>T.-Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Lactate: a multifunctional signaling molecule</article-title>. <source>Yeungnam Univ. J. Med.</source> <volume>38</volume>, <fpage>183</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.12701/YUJM.2020.00892</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z. H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Inhibition of glycolysis by targeting lactate dehydrogenase A facilitates hyaluronan synthase 2 synthesis in synovial fibroblasts of temporomandibular joint osteoarthritis</article-title>. <source>Bone</source> <volume>141</volume>, <fpage>115584</fpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2020.115584</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Lactate metabolism in human health and disease</article-title>. <source>Signal Transduct. Target. Ther.</source> <volume>7</volume> (<issue>1</issue>), <fpage>305</fpage>&#x2013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1038/s41392-022-01151-3</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Host defense against the infection of klebsiella pneumoniae: new strategy to kill the bacterium in the era of antibiotics?</article-title> <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>, <fpage>1050396</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2022.1050396</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuei</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shelton</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume>, <fpage>2811</fpage>&#x2013;<lpage>2822</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M806409200</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Energy metabolism in health and diseases</article-title>. <source>Signal Transduct. Target Ther.</source> <volume>10</volume>, <fpage>69</fpage>. <pub-id pub-id-type="doi">10.1038/S41392-025-02141-X</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Lactate and lactylation in sepsis: a comprehensive review</article-title>. <source>J. Inflamm. Res.</source> <volume>17</volume>, <fpage>4405</fpage>&#x2013;<lpage>4417</lpage>. <pub-id pub-id-type="doi">10.2147/JIR.S459185</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Lactobacillus plantarum CCFM8610 alleviates irritable bowel syndrome and prevents gut microbiota dysbiosis: a randomized, double-blind, placebo-controlled, pilot clinical trial</article-title>. <source>Engineering</source> <volume>7</volume>, <fpage>376</fpage>&#x2013;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1016/J.ENG.2020.06.026</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llibre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grudzinska</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>O&#x2019;Shea</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Duffy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Thickett</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Mauro</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Lactate cross-talk in host&#x2013;pathogen interactions</article-title>. <source>Biochem. J.</source> <volume>478</volume>, <fpage>3157</fpage>&#x2013;<lpage>3178</lpage>. <pub-id pub-id-type="doi">10.1042/BCJ20210263</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llibre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kucuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gope</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Certo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mauro</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Lactate: a key regulator of the immune response</article-title>. <source>Immunity</source> <volume>58</volume>, <fpage>535</fpage>&#x2013;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1016/J.IMMUNI.2025.02.008</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>P. O.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Microbial lactate utilisation and the stability of the gut microbiome</article-title>. <source>Gut Microbiome</source> <volume>3</volume>, <fpage>e3</fpage>. <pub-id pub-id-type="doi">10.1017/GMB.2022.3</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X. T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q. Q.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>P. C. K.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>How probiotics, prebiotics, synbiotics, and postbiotics prevent dental caries: an oral microbiota perspective</article-title>. <source>Biofilms Microbiomes</source> <volume>10</volume> (<issue>1</issue>), <fpage>14</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/s41522-024-00488-7</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandadzhiev</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>The contemporary role of lactate in exercise physiology and exercise prescription &#x2013; a review of the literature</article-title>. <source>Folia Medica</source> <volume>67</volume> (<issue>1</issue>), <fpage>e144693</fpage>. <pub-id pub-id-type="doi">10.3897/FOLMED.67.E144693</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed;n</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rios-Covian</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Huillet</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Auger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khazaal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Berm&#xfa;dez-Humar&#xe1;n</surname>
<given-names>L. G.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Faecalibacterium: a bacterial genus with promising human health applications</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>47</volume>, <fpage>fuad039</fpage>. <pub-id pub-id-type="doi">10.1093/FEMSRE/FUAD039</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melkonian</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Asuka</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schury</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2023</year>). <source>Physiology, Gluconeogenesis</source>. <publisher-loc>Treasure Island, FL</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>. . <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK541119/">https://www.ncbi.nlm.nih.gov/books/NBK541119/</ext-link>.</comment>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendonca</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Alghamdi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Messeha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Soliman</surname>
<given-names>K. F. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Pentagalloyl glucose inhibits TNF&#x2010;&#x3b1;&#x2010;activated CXCL1/GRO-&#x3b1; expression and induces apoptosis&#x2010;related genes in triple-negative breast cancer cells</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <fpage>5649</fpage>. <pub-id pub-id-type="doi">10.1038/S41598-021-85090-Z</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stumvoll</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dostou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Welle</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Haymond</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gerich</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Renal substrate exchange and gluconeogenesis in normal postabsorptive humans</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source> <volume>282</volume>, <fpage>428</fpage>&#x2013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1152/AJPENDO.00116.2001</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duranti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bottacini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Turroni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mahony</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>81</volume>, <fpage>e00036-17</fpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00036-17</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moser</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>P. &#xd8;.</given-names>
</name>
<name>
<surname>Thomsen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kolpen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rybtke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lauland</surname>
<given-names>A. S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Immune responses to <italic>Pseudomonas aeruginosa</italic> biofilm infections</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <fpage>625597</fpage>. <pub-id pub-id-type="doi">10.3389/FIMMU.2021.625597</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nalbandian</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Radak</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Active recovery between interval bouts reduces blood lactate while improving subsequent exercise performance in trained men</article-title>. <source>Sports</source> <volume>5</volume>, <fpage>40</fpage>. <pub-id pub-id-type="doi">10.3390/SPORTS5020040</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nareika</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Game</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Slate</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>London</surname>
<given-names>S. D.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Sodium lactate increases LPS-Stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-kappaB transcriptional activities</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source> <volume>289</volume>, <fpage>534</fpage>&#x2013;<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00462.2004</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Balling</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>The warburg effect reinterpreted 100 yr on: a first-principles stoichiometric analysis and interpretation from the perspective of ATP metabolism in cancer cells</article-title>. <source>Function</source> <volume>5</volume>, <fpage>zqae008</fpage>. <pub-id pub-id-type="doi">10.1093/FUNCTION/ZQAE008</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Metabolic engineering of <italic>Escherichia coli</italic> for the <italic>de novo</italic> stereospecific biosynthesis of 1,2-propanediol through lactic acid</article-title>. <source>Metab. Eng. Commun.</source> <volume>8</volume>, <fpage>e00082</fpage>. <pub-id pub-id-type="doi">10.1016/J.MEC.2018.E00082</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouyang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The role of lactate in cardiovascular diseases</article-title>. <source>Cell Commun. Signal</source> <volume>21</volume>, <fpage>317</fpage>. <pub-id pub-id-type="doi">10.1186/S12964-023-01350-7</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagliarini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Podrini</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Metabolic reprogramming and reconstruction: integration of experimental and computational studies to set the path forward in ADPKD</article-title>. <source>Front. Med. (Lausanne)</source> <volume>8</volume>, <fpage>740087</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2021.740087</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pellerin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Magistretti</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>91</volume>, <fpage>10625</fpage>&#x2013;<lpage>10629</lpage>. <pub-id pub-id-type="doi">10.1073/PNAS.91.22.10625</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>T. Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y. H.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>The role of lactate metabolism and lactylation in pulmonary arterial hypertension</article-title>. <source>Respir. Res.</source> <volume>26</volume>, <fpage>99</fpage>. <pub-id pub-id-type="doi">10.1186/S12931-025-03163-3</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penna-Coutinho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cortopassi</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Fran&#xe7;a</surname>
<given-names>T. C. C.</given-names>
</name>
<name>
<surname>Krettli</surname>
<given-names>A. U.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies</article-title>. <source>PLoS One</source> <volume>6</volume>, <fpage>e21237</fpage>. <pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0021237</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrariu</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Barbu</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Niculescu</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Constantin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grigore</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Cristian</surname>
<given-names>R. E.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases</article-title>. <source>Front. Microbiol.</source> <volume>14</volume>, <fpage>1296447</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2023.1296447</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Portincasa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Khalil</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Graziani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fr&#xfc;hbeck</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Baffy</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Garruti</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?</article-title> <source>Eur. J. Intern Med.</source> <volume>119</volume>, <fpage>13</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/J.EJIM.2023.10.002</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Possemiers</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vandermosten</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Van Den Steen</surname>
<given-names>P. E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Etiology of lactic acidosis in malaria</article-title>. <source>PLoS Pathog.</source> <volume>17</volume>, <fpage>e1009122</fpage>. <pub-id pub-id-type="doi">10.1371/JOURNAL.PPAT.1009122</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rai</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Mott</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Benavides</surname>
<given-names>G. A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Pyrazole-based lactate dehydrogenase inhibitors with optimized cell activity and pharmacokinetic properties</article-title>. <source>J. Med. Chem.</source> <volume>63</volume>, <fpage>10984</fpage>&#x2013;<lpage>11011</lpage>. <pub-id pub-id-type="doi">10.1021/ACS.JMEDCHEM.0C00916</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ranganathan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shanmugam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Swafford</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Suryawanshi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bhattacharjee</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hussein</surname>
<given-names>M. S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>GPR81, a cell-surface receptor for lactate, regulates intestinal homeostasis and protects mice from experimental colitis</article-title>. <source>J. Immunol.</source> <volume>200</volume>, <fpage>1781</fpage>&#x2013;<lpage>1789</lpage>. <pub-id pub-id-type="doi">10.4049/JIMMUNOL.1700604</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rastogi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Gut microbiome and human health: exploring how the probiotic genus lactobacillus modulate immune responses</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <fpage>1042189</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.1042189</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reichardt</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Belenguer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McWilliam Leitch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>K. P.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Phylogenetic distribution of three pathways for propionate production within the human gut microbiota</article-title>. <source>ISME J.</source> <volume>8</volume>, <fpage>1323</fpage>&#x2013;<lpage>1335</lpage>. <pub-id pub-id-type="doi">10.1038/ISMEJ.2014.14</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Revelly</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Tappy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bollmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cayeux</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>M. M.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Lactate and glucose metabolism in severe sepsis and cardiogenic shock</article-title>. <source>Crit. Care Med.</source> <volume>33</volume>, <fpage>2235</fpage>&#x2013;<lpage>2240</lpage>. <pub-id pub-id-type="doi">10.1097/01.CCM.0000181525.99295.8F</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rey</surname>
<given-names>F. E.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ahern</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Metabolic niche of a prominent sulfate-reducing human gut bacterium</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>110</volume>, <fpage>13582</fpage>&#x2013;<lpage>13587</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1312524110</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogatzki</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Goodwin</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Gladden</surname>
<given-names>L. B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Lactate is always the end product of glycolysis</article-title>. <source>Front. Neurosci.</source> <volume>9</volume>, <fpage>22</fpage>. <pub-id pub-id-type="doi">10.3389/FNINS.2015.00022</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>K. O.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures</article-title>. <source>Front. Pharmacol.</source> <volume>14</volume>, <fpage>1187819</fpage>. <pub-id pub-id-type="doi">10.3389/FPHAR.2023.1187819</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Said</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Tirthani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lesho</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Enterococcus infections. 1&#x2013;15</article-title>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK567759/">https://www.ncbi.nlm.nih.gov/books/NBK567759/</ext-link>(Accessed April 25, 2025)</comment>.</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saleem</surname>
<given-names>G. N.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bahar Khaskheli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rashid Rajput</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Qasim</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Therapeutic potential of popular fermented dairy products and its benefits on human health</article-title>. <source>Front. Nutr.</source> <volume>11</volume>, <fpage>1328620</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2024.1328620</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schurr</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Payne</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Rigor</surname>
<given-names>B. M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons</article-title>. <source>J. Neurosci.</source> <volume>19</volume>, <fpage>34</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-01-00034.1999</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sehgal</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface</article-title>. <source>Ther. Adv. Gastroenterol.</source> <volume>14</volume>, <fpage>1756284821994736</fpage>. <pub-id pub-id-type="doi">10.1177/1756284821994736</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Polygala tenuifolia root extract attenuates ischemic stroke by inhibiting HMGB1 trigger neuroinflammation</article-title>. <source>Fitoterapia</source> <volume>180</volume>, <fpage>106280</fpage>. <pub-id pub-id-type="doi">10.1016/J.FITOTE.2024.106280</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Shadan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Biotechnological applications of probiotics: a multifarious weapon to disease and metabolic abnormality</article-title>. <source>Probiotics Antimicrob. Proteins</source> <volume>14</volume> (<issue>6</issue>), <fpage>1184</fpage>&#x2013;<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.1007/S12602-022-09992-8</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somiah</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gebremariam</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Smirnova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>A. B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Lactate causes downregulation of <italic>Helicobacter pylori</italic> adhesin genes sabA and labA while dampening the production of proinflammatory cytokines</article-title>. <source>Sci. Rep.</source> <volume>12</volume>, <fpage>20064</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/S41598-022-24311-5</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Bryant</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2022</year>) &#x201c;<article-title>Streptococcus pyogenes impetigo, erysipelas, and cellulitis</article-title>,&#x201d; in <source>Streptococcus pyogenes: basic biology to clinical manifestations</source>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK587091/">https://www.ncbi.nlm.nih.gov/books/NBK587091/</ext-link>(Accessed April 25, 2025)</comment>.</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Bozdagi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Huntley</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Magistretti</surname>
<given-names>P. J.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Astrocyte-neuron lactate transport is required for long-term memory formation</article-title>. <source>Cell</source> <volume>144</volume>, <fpage>810</fpage>&#x2013;<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.02.018</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeda</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nonaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kakinoki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hoshino</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Effect of endurance training and PGC-1&#x3b1; overexpression on calculated lactate production volume during exercise based on blood lactate concentration</article-title>. <source>Sci. Rep.</source> <volume>12</volume>, <fpage>1635</fpage>. <pub-id pub-id-type="doi">10.1038/S41598-022-05593-1</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarnopolsky</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Myopathies related to glycogen metabolism disorders</article-title>. <source>Neurotherapeutics</source> <volume>15</volume>, <fpage>915</fpage>&#x2013;<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1007/S13311-018-00684-2</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Unakal</surname>
<given-names>C. G.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>
<italic>Staphylococcus aureus</italic> infection</article-title>. <source>Encycl. Food Saf.</source> (<issue>1&#x2013;4</issue>), <fpage>V2</fpage>&#x2013;<lpage>V310</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-822521-9.00048-4</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Todorov</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Dioso</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Liong</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Nero</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Khosravi-Darani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>I. V.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Beneficial features of pediococcus: from starter cultures and inhibitory activities to probiotic benefits</article-title>. <source>World J. Microbiol. Biotechnol.</source> <volume>39</volume>, <fpage>4</fpage>. <pub-id pub-id-type="doi">10.1007/S11274-022-03419-W</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tripathi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Panesar</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Taufeeq</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rustagi</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Fermentative production of vitamin B12 by propionibacterium shermanii and Pseudomonas denitrificans and its promising health benefits: a review</article-title>. <source>Food Sci. Nutr.</source> <volume>12</volume>, <fpage>8675</fpage>&#x2013;<lpage>8691</lpage>. <pub-id pub-id-type="doi">10.1002/FSN3.4428</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tufail</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Exploring the probiotic potential of bacteroides spp. within one health paradigm</article-title>. <source>Probiotics Antimicrob. Proteins</source> <volume>17</volume> (<issue>2</issue>), <fpage>681</fpage>&#x2013;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1007/S12602-024-10370-9</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valvona</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Fillmore</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Nunn</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Pilkington</surname>
<given-names>G. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The regulation and function of lactate dehydrogenase A: therapeutic potential in brain tumor</article-title>. <source>Brain Pathol.</source> <volume>26</volume>, <fpage>3</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1111/BPA.12299</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vav&#x159;i&#x10d;ka</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bro&#x17e;</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Follprecht</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nov&#xe1;k</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Krou&#x17e;eck&#xfd;</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Modern perspective of lactate metabolism</article-title>. <source>Physiol. Res.</source> <volume>73</volume>, <fpage>499</fpage>&#x2013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.33549/PHYSIOLRES.935331</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Victoria Obayomi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Folakemi Olaniran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Olugbemiga Owa</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Unveiling the role of functional foods with emphasis on prebiotics and probiotics in human health: a review</article-title>. <source>J. Funct. Foods</source> <volume>119</volume>, <fpage>106337</fpage>. <pub-id pub-id-type="doi">10.1016/J.JFF.2024.106337</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vieco-Saiz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Belguesmia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Raspoet</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Auclair</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gancel</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kempf</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Benefits and inputs from lactic acid bacteria and their bacteriocins as alternatives to antibiotic growth promoters during food-animal production</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>, <fpage>57</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.00057</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F. X.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z. A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. X.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Lactylation: a promising therapeutic target in ischemia-reperfusion injury management</article-title>. <source>Cell Death Discov.</source> <volume>11</volume>, <fpage>100</fpage>. <pub-id pub-id-type="doi">10.1038/S41420-025-02381-4</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Rubio</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Donachie</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Holtrop</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Pivotal roles for pH, lactate, and lactate-utilizing bacteria in the stability of a human colonic microbial ecosystem</article-title>. <source>mSystems</source> <volume>5</volume>, <fpage>e00645-20</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1128/MSYSTEMS.00645-20</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F. Q.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Pyruvate is a prospective alkalizer to correct hypoxic lactic acidosis</article-title>. <source>Mil. Med. Res.</source> <volume>5</volume>, <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/S40779-018-0160-Y</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Mitochondrial diseases: from molecular mechanisms to therapeutic advances</article-title>. <source>Signal Transduct. Target. Ther.</source> <volume>10</volume> (<issue>1</issue>), <fpage>9</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1038/s41392-024-02044-3</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheless</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weatherspoon</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Use of stiripentol in Dravet syndrome: a guide for clinicians</article-title>. <source>Pediatr. Neurol.</source> <volume>162</volume>, <fpage>76</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/J.PEDIATRNEUROL.2024.10.015</pub-id>
</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Atefi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Elshimali</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vadgama</surname>
<given-names>J. V.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Lactate, a neglected factor for diabetes and cancer interaction</article-title>. <source>Mediat. Inflamm.</source> <volume>2016</volume>, <fpage>6456018</fpage>. <pub-id pub-id-type="doi">10.1155/2016/6456018</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>R.-Y.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Lactate metabolism in neurodegenerative diseases</article-title>. <source>Neural Regen. Res.</source> <volume>19</volume>, <fpage>69</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.374142</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Natural products targeting human lactate dehydrogenases for cancer therapy: a mini review</article-title>. <source>Front. Chem.</source> <volume>10</volume>, <fpage>1013670</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2022.1013670</pub-id>
</citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Metabolic interactions of host-gut microbiota: new possibilities for the precise diagnosis and therapeutic discovery of gastrointestinal cancer in the future&#x2014;A review</article-title>. <source>Crit. Rev. Oncol. Hematol.</source> <volume>203</volume>, <fpage>104480</fpage>. <pub-id pub-id-type="doi">10.1016/J.CRITREVONC.2024.104480</pub-id>
</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Metabolic regulation of gene expression by histone lactylation</article-title>. <source>Nature</source> <volume>574</volume>, <fpage>575</fpage>&#x2013;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1678-1</pub-id>
</citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Lactate dehydrogenase-inhibitors isolated from ethyl acetate extract of Selaginella doederleinii by using a rapid screening method with enzyme-immobilized magnetic nanoparticles</article-title>. <source>Front. Biosci. - Landmark</source> <volume>27</volume>, <fpage>229</fpage>. <pub-id pub-id-type="doi">10.31083/j.fbl2708229</pub-id>
</citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2024a</year>). <article-title>Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets</article-title>. <source>Front. Cardiovasc Med.</source> <volume>11</volume>, <fpage>1489438</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2024.1489438</pub-id>
</citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kueth</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2024b</year>). <article-title>Lactate&#x2019;s impact on immune cells in sepsis: unraveling the complex interplay</article-title>. <source>Front. Immunol.</source> <volume>15</volume>, <fpage>1483400</fpage>. <pub-id pub-id-type="doi">10.3389/FIMMU.2024.1483400</pub-id>
</citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M. H.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Lactate cross-feeding between bifidobacterium species and Megasphaera indica contributes to butyrate formation in the human colonic environment</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>90</volume>, <fpage>e0101923</fpage>. <pub-id pub-id-type="doi">10.1128/AEM.01019-23</pub-id>
</citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications</article-title>. <source>J. Hematol. &#x26; Oncol.</source> <volume>15</volume> (<issue>15</issue>), <fpage>160</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1186/S13045-022-01358-5</pub-id>
</citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Lactate and lactylation in cardiovascular diseases: current progress and future perspectives</article-title>. <source>Metabolism</source> <volume>158</volume>, <fpage>155957</fpage>. <pub-id pub-id-type="doi">10.1016/J.METABOL.2024.155957</pub-id>
</citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zymli&#x144;ski</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Biegus</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sokolski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Siwo&#x142;owski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nawrocka-Millward</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion</article-title>. <source>Eur. J. Heart Fail</source> <volume>20</volume>, <fpage>1011</fpage>&#x2013;<lpage>1018</lpage>. <pub-id pub-id-type="doi">10.1002/EJHF.1156</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>